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Airway diseases including Chronic obstructive pulmonary diseases (COPD), 
Idiopathic pulmonary fibrosis (IPF) and Acute respiratory distress syndrome 
(ARDS), are listed as the third largest killer worldwide accounting for millions of 
deaths every year. Influenza virus infections have resulted in some of the most 
devastating pandemics in world history including the 1918 Spanish flu, which 
killed millions of people worldwide. Influenza-induced ARDS is characterized by 
massive infiltration of immune cells and cytokines along with widespread damage 
to the airway epithelium. The possible stem cell regeneration of the damaged 
epithelium post infection remains unexplored. While p63+ Krt5+ cells have been 
implicated as the stem cells of the upper airways, stem cells of the lower airways 
(which participate in oxygen exchange) is still questionable. 
 
In this study, we developed a mouse model to study H1N1-induced lung damage 
and repair. A murine-adapted H1N1 influenza virus induced viral pneumonia 
similar to that observed in humans, with damage to the bronchial as well as 
alveolar epithelium. A sub-lethal dose of the virus induced sufficient damage in 
mouse lungs and allowed careful investigation of the repair process post infection. 
Detailed analyses revealed that p63+ Krt5+ basal stem cells are responsible for 
the repair of the upper airways mirroring several chemical lung injury model 
studies. Interestingly, we also observed p63+ Krt5+ pods in the damaged 
interstitial regions during the repair initiation phase. We demonstrate that this 
epithelial cell population is actively proliferating in vivo and also has 
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clonogenic ability in vitro. Further, in vitro, p63+ Krt5+ mouse lung stem cells 
differentiate into cell types of upper as well as lower airways. Morphological 
analysis and expression patterns of cell type-specific markers revealed a possible 
alveolar type I fate of the Krt5+ pods independent of an alveolar type II cell 
transition. Gene expression profiling of the pods during the course of the repair 
process also suggested an alveolar differentiation of the Krt5+ pods accompanied 
by the necessary development of endothelial capillary beds to form potentially 
functional alveolar units. We also employed genetic tracing systems to track the 
p63+ Krt5+ cells underlying the basal layer of the bronchial epithelium, migrating 
into adjacent interstitial regions during extreme damage conditions, to regenerate 
alveolar epithelium. This work was strongly supported by parallel studies in the 
Xian-McKeon lab on pedigree analysis of human airway stem cells illustrating 
that p63+ Krt5+ distal airway stem cells can differentiate into alveolar epithelium 
in vitro.  
  
Overall, this study demonstrates the potential of p63+ Krt5+ stem cells to 
regenerate bronchial as well as alveolar epithelium post H1N1 induced lung 
damage. Gene expression analyses of the Krt5+ pods observed in vivo provides us 
with candidate genes and key pathways that can be targeted to understand and 
manipulate the proliferation, migration and differentiation potential of these cells. 
The ultimate goal will be to dissect out the underlying mechanisms participating 
in the synchronized regeneration of different aspects of the airways to develop 
novel therapeutic intervention to treat patients with life threatening ARDS. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Lung architecture 
The respiratory system of an organism performs the function of gas exchange. 
The lungs are a major component of the respiratory system for most mammals, 
and are responsible for exchange of oxygen from the atmosphere to the 
bloodstream and the release of carbon dioxide from the blood into the atmosphere. 
The lung is a complex organ with a heterogeneous cell population and is most 
commonly divided into two anatomically distinct epithelial domains, namely the 
conducting airways and the gas-exchanging airspaces. The conducting airways 
can further be divided into two compartments, namely the cartilaginous 
tracheobronchial airways and the bronchiolar airways while the gas exchange 
airspaces consist of alveolar networks (Fig. 1).  
 
The trachea and the bronchi, together known as the conducting or upper or 
proximal airways, consist of a stratified columnar epithelium populated with 
mainly ciliated cells (identified by  tubulin IV) and secretory cells. In humans 
the secretory cell population in the upper airways is predominantly the Goblet 
cells (identified by Muc5ac, a mucous marker) while in mouse it is the Clara cells 
(identified by Clara cell 10 protein, CC10), and less frequently the pulmonary 
neuroendocrine cells (PNEC). This epithelium is underlined by relatively rare 
basal cells that are believed to be the progenitor cell population of the upper 
airways. The bronchi and bronchioles are comprised mostly of columnar Clara 
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cells interspersed with ciliated cells (in both human and mouse). The main 
function of the conducting airways is to conduct air to and from the alveoli and to 
protect the lungs from toxic substances and pathogens. The distal, small or lower 
airways comprise of small respiratory bronchioles and alveolar region. The 
alveolar network consists of alveolar type I cells (identified by Podoplanin, 
PDPN) and cuboidal alveolar type II cells (identified by surfactant protein C, 
SPC), (Bannister, 1999). The alveolar type I cells are thin walled cells where gas 
exchange takes place, and the alveolar type II cells release surfactants to maintain 
the surface tension at the air-water interface and also act as a progenitor cell 
population for alveolar type I cells (Fehrenbach, 2001; Liu et al., 2006; Mason 
and Williams, 1977; Rawlins and Hogan, 2006). 
 
 
Figure 1 : Lung architecture 
Clara cells (CC10, green) and ciliated cells ( tubulin IV red) line the 
tracheobronchial epithelium of the upper or proximal airways. Interspersed basal 
cells (p63, red) underlie the differentiated epithelium in the upper cartilaginous 
airways. Neuroendocrine cells (CGRP, red) are present in the neuroepithelial 
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bodies in the upper airways. Image adapted from Rawlins and Hogan, 2006). The 
lower or distal airways consist of the respiratory bronchioles opening up into 
alveolar sacs. The alveolar region consists of alveolar type I cells (PDPN, green) 
and alveolar type II cells (SPC, red). Architecture of the lung adapted from Liu et 
al., 2006. 
 
1.2 Lung development  
Human lung organogenesis and development consists of five distinct stages (Post 
and Copland, 2002). The early phases of development comprises of the first two 
stages namely the embryonic (day 26 to 52) and pseudoglandular (day 52 to end 
of 16 weeks of gestation) phases. During these initial phases the hierarchical 
structure of the system with conductive airways and visible acinar limits are 
visible. In the pseudoglandular phase, a combined development involving 
primitive airway epithelium differentiation consisting of neuroendocrine, ciliated 
and goblet cells as well as mesenchymal cell differentiation to form cartilage and 
smooth muscle cells is observed (Jeffery, 1998). In the following canalicular 
phase (17-26 weeks of gestation), the airway branching pattern with respiratory 
bronchioles are formed. The development of the lower airways is also initiated 
with increase in vascularization, and differentiation of alveolar type I and II cells 
releasing surfactants in prospective gas exchange regions (DiFiore and Wilson, 
1994). In the following terminal sac phase (24-36 weeks to term), the important 
steps which occur are the growth of the pulmonary parenchyma, the thinning of 
the connective tissue between the airspaces and the further maturation of the 
surfactant system. At birth, the air spaces present are smooth-walled transitory 
ducts and saccules with primitive septa that are thick and contain a double 
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capillary network. Although fetal breathing movements are identified by only 8 
weeks of development (De Vries et al., 1982), and the lungs are also functional at 
birth, structurally, the alveoli which are the functional gas exchange units of the 
adult lungs are not developed. The immature air spaces mature into alveoli 
through a septation process during the post natal alveolar phase, which is from 36 
weeks to term and at least 36 months postnatal (Burri, 1984). 
 
The development of mouse lung is relatively similar to that of human lung 
development and has been divided in four histological phases (Cardoso and Lü, 
2006). Embryonic day (E) 10.5-16.5 is known as the pseudoglandular phase 
where branching morphogenesis takes place and the bronchiolar tree is formed. 
Further, the epithelium starts differentiating into Clara, neuroendocrine, and 
ciliated cells (Metzger et al., 2008). The next stage (E16.5-17.5) is the canalicular 
phase where the undifferentiated distal epithelium continues to branch and form 
terminal sacs. In the terminal sac phase (E17.5- postnatal day (P) 5), the number 
of terminal sacs continues to increase and the type I and II alveolar epithelial cells 
begin to develop. The terminal sac develops into mature alveoli during the 
alveolar phase (P5-30).  
 
1.3 Airway diseases 
Diseases of the airways such as asthma and chronic obstructive pulmonary 
disease (COPD), and parenchymal lung diseases such as idiopathic pulmonary 
fibrosis (IPF), pulmonary hypertension, pneumonia, and acute respiratory damage 
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syndrome (ARDS) are on the rise every year. After heart diseases and cancer, the 
US Centre for Disease control listed respiratory diseases including COPD, IPF 
and ARDS as the third largest killer, affecting about 600 million individuals 
worldwide in 2007 (Balkissoon et al., 2011; Tansey et al., 2007; Xian and 
McKeon, 2012). 
 
COPD, also known as chronic obstructive lung disease (COLD), or chronic 
obstructive respiratory disease (CORD), is caused by the occurrence of chronic 
bronchitis or emphysemas. This leads to the narrowing of the airways, which 
subsequently limits the flow of air to and from the lungs resulting in dyspnea or 
shortness of breath (National Heart Lung and Blood Institute, 2010). Tobacco 
smoke is the most recognized cause for COPD globally. There are however other 
exposures that can cause COPD related to occupation or environment such as 
organic and inorganic dusts, chemical fumes, smoke, biomass fuels etc (Blanc et 
al., 2009). 20% - 30% of individuals who smoke develop evidence of COPD 
(Balkissoon et al., 2011), and COPD alone is amongst the leading five causes of 
death worldwide (Mathers and Loncar, 2006). Investigators have used several 
approaches to study COPD in animal models. For example, targeted disruption of 
the cystic fibrosis transmembrane receptor gene (CFTR) in pigs recapitulated 
human cystic fibrosis quiet accurately (Rogers et al., 2008a; Rogers et al., 2008b). 
Genetic approaches including over-expression or knock-down of COPD relevant 
human genes in mice (Baron et al., 2011) in combination with cigarette exposure 
models are more commonly used (Baron et al., 2011; Shapiro, 2007). 
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IPF, or cryptogenic fibrosing alveolitis (CFA), is a progressive and commonly 
fatal disease. It is characterized by sequential acute lung injury, and chronic 
inflammation with subsequent scarring due to extensive fibroblast proliferation 
and extracellular matrix remodeling (Fellrath and Bois, 2003; Gribbin et al., 2006). 
IPF is associated with a pathological lesion known as usual interstitial pneumonia 
(UIP). UIP shows a pattern of normal lung structure alternating with patches of 
dense fibrosis as a result of patchy fibroblast-myofibroblast foci. Exercise-
induced breathlessness and chronic dry cough are the prevalent symptoms 
(Meltzer and Noble, 2008). This chronic disease affects an estimated 5 million 
people all over the world and during the last decade, the incidence of IPF appears 
to be on the rise (Gribbin et al., 2006; Meltzer and Noble, 2008) . The most 
common models to study IPF include that of bleomycin (Moeller et al., 2008), and 
Tgf1 transgenic mouse models (Zhou et al., 1996).  
 
First described in 1967, ARDS, or acute lung injury (ALI) is a lung condition that 
leads to low oxygen levels in the blood (Ashbaugh et al., 1967). ARDS is caused 
mainly by extensive lung inflammation and small blood vessel injury due to 
sepsis (bacterial infection of the blood), trauma and/or severe pulmonary infection 
such as pneumonia. Pathologically, ARDS is characterized by diffuse alveolar 
damage and pneumonia. The massive infiltration in the lung parenchyma causes 
the alveolar sacs to be filled with inflammatory cells and cytokines which impairs 
normal gas exchange functions of the lungs. While the mortality rate of ARDS 
has improved over the years, the incidence of ARDS in the United Stated is 
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predicted to be 78.9/100,000 persons per year, with a mortality rate of 
approximately 40%-50% per year (Mancebo et al., 2006; Rubenfeld et al., 2005; 
Singer et al., 2006; Zambon and Vincent, 2008). In 2007, the National Heart, 
Lung and Blood Institute estimated that approximately 190,000 Americans are 
affected by ARDS annually (NIH, 2007). Although the histopathology of the 
survivors in human is not accessible, most patients that survive recover their 
normal lung function in terms of near-normal ranges of spirometry and oxymeter 
readings within a year of the disease (Tansey et al., 2007) suggesting a normal 
recovery process.  
 
Mouse models of ARDS are commonly induced by ventilator-induced lung injury 
(VILI) and hyperoxia (Hosford et al., 2004). Bacterial infection models have also 
been used in the past in combination with genetically engineered mice involving 
knock-out or over-expression of different classes of genes including molecules 
involved in chemoattractant pathways, Toll like receptors and other inflammatory 
pathways (Albiger et al., 2007; Chen et al., 2001; Ye et al., 2001). Tissue and 
temporal specificity add additional control in these experiments. In VILI, mice are 
ventilated with high tidal volumes for 2–8 hours. This causes alveolar stretching 
which in return induces lung injury. Although the system is clinically very 
relevant, tidal volumes as high as 20–35 ml/kg would never be considered for 
human use. Short-term hyperoxic exposure models also result in ARDS in mice. 
However, a limitation to the use of this hyperoxia model is that the profound lung 
injury that mice exhibit is not observed in humans, making the system more 
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artificial (Matute-Bello et al., 2008). As a result, researchers have resorted to 
using “two-hit” models, which require sequential lung injuries as this reflects 
clinical disease more accurately (e.g., development of sepsis, followed by the 
need for mechanical ventilation). The disadvantages of these dual-injury models 
are that they are time intensive, complicated to reproduce, and the interpretations 
of the biological effects of these injuries become more complex.  
 
One of the major causes of ARDS is viral pneumonia. Several serotypes of 
Influenza A virus including H1N1 and H5N1 have caused severe viral pneumonia 
which leads to patients dying of progressively complicated ARDS (Grose, 2004; 
Perez-Padilla et al., 2009); Centers for Disease Control and Prevention, 2004). In 
our study we investigate this influenza virus induced ARDS further. 
 
1.4 Influenza virus 
Influenza virus is a negative-sense ssRNA virus belonging to the 
Orthomyxoviridae family. This family consists of five genera, three of which 
include the influenza viruses namely Influenza virus A, Influenza virus B, and 
Influenza virus C (International Committee on taxonomy of Viruses). These three 
genera infect vertebrates and are characterized by the differences in their matrix 
proteins and nuclear proteins.   
 
Influenza virus A is the most common and can infect human, mammals and birds 
while Influenza virus B and C are less common, and can infect humans as well as 
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seals and pigs respectively. Influenza virus causes flu, and is commonly 
misinterpreted as the common cold caused by rhinovirus. The Influenza A 
genome consists of eight single-stranded negative sense RNA molecules encoding 
a total of 11 proteins which include hemagglutinin (HA), neuraminidase (NA), 
nucleoprotein (NP), M1, M2, NS1, NS2 (NEP: nuclear export protein), PA, PB1 
(polymerase basic 1), PB1-F2 and PB2 (Ghedin et al., 2005). Influenza A virus 
can be further classified based on the 16 hemagglutinin (HA or H) and nine 
neuraminidase (NA or N) serotypes.  
 
Influenza viruses continue to evolve and give rise to several epidemics and 
pandemics (Hay et al., 2001). A phenomenon called antigenic drift occurs in 
Influenza A and B viruses due to the mutability of the RNA genome which leads 
to recurrent annual epidemics of the disease. Further, because of the segmented 
RNA genome of the Influenza A virus, they have the ability to undergo genetic 
reassortments during mixed infections resulting in a phenomenon called antigenic 
shift. This infrequent phenomenon leads to severe pandemics because of the low 
immunity of people to these novel strains.  
 
Influenza viruses have the ability to cause sudden, pervasive illnesses in all age 
groups of the human population on a global scale. The virus has caused several 
pandemics like the 1918 Spanish flu (H1N1), the 1957 Asian Flu (H2N2), the 
1968 Hong Kong flu (H3N2), and more recently the 2009 swine flu (H1N1) 
pandemic (Hilleman, 2002; Potter, 2001; WHO, 2005). The influenza pandemic 
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of 1918-1919 has been cited as the most devastating epidemic in recorded world 
history killing more people than the Great War (World War I), at somewhere 
between 50-100 million people (Johnson and Mueller, 2002). Even today 
influenza spreads around the world in seasonal epidemics, resulting in the deaths 
of between 250,000 and 500,000 people every year (WHO, 2010). Autopsy on 
1918 patient samples revealed that there was an uncontrolled inflammatory 
response resulting in extensive tissue damage in the lung which ultimately led to 
lung failure and death of millions of people (Knobler, 2005). Investigations of 
recent influenza pandemics revealed that death was often associated with 
widespread viral antigen expression in, and damage to, respiratory epithelia in the 
tracheobronchial as well as alveolar regions, secondary bacterial infections and 
ultimately multiple organ failure (Gill et al., 2010; Lowy, 2003; Wu et al., 2011). 
Influenza virus A induces interstitial pneumonia, characterized by a rapid onset of 
inflammatory cytokines and immune cell infiltration resulting in, diffuse alveolar 
damage and associated hypoxemia (Berthiaume et al., 1999; Matuschak and 
Lechner, 2010; Ramsey and Kumar, 2011).    
 
Although we understand the causes and terminal pathology of H1N1 influenza 
induced ARDS, the recovery processes from ARDS is still unclear. ARDS 
patients show improved lung function six to twelve months after the disease, but 
some patients still exhibit both pulmonary and extrapulmonary deficits in the long 
term (Herridge et al., 2003). Whether this recovery involves adaptive remodeling 
or stem cell induced regenerative process remains an area of intense study. It can 
be hypothesized that local stem cell populations are involved in the regenerative 
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process and this area of study could provide a new insight into airway recovery 
mechanisms. 
1.5 Lung stem cells 
Most adult tissues such as gastrointestinal tract, skin, and blood are believed to 
contain multipotent stem cells. These populations of cells are essential for 
maintaining normal self-renewal and homeostasis (Fuchs and Segre, 2000; Fuchs 
et al., 2004). They can undergo long-term self-renewal, as well as produce transit 
amplifying progenitor cells that can self-renew in the short term and also give rise 
to tissue-specific differentiated cell types. The lungs are constantly exposed to 
harmful pollutants and pathogens and yet they exhibit the capability to recover 
from the adverse effects. Hence it is critical to study the stem cell populations in 
the lung and elucidate the underlying pathways and key molecules involved. The 
time needed to replace all cells of a given population, termed cell turn-over time, 
is quite variable and depends on the specific tissue, developmental stage or age, 
and pathogenic conditions. At steady state, the airway epithelia have a very low 
turnover rate. The turnover rates can be as small as two to ten days for bronchial 
epithelium of adult mammals, and 4-5 weeks for the alveolar epithelium (Bowden, 
1983). Owing to the low turn-over rate of the lung epithelium, stem cells in the 
lung have been most commonly studied using ex vivo systems like xenograft 
models, in vivo studies like chemical injury models, or in vitro culture systems 
(Liu et al., 2006). 
 
Recently, Rawlins and colleagues (Rawlins et al., 2009a) identified an Id2+ self-
12 
 
renewing, multipotent progenitor cell population in the pseudoglandular stage of 
mouse lung development that can contribute to all epithelial cell lineages, 
including the bronchial epithelium, alveolar epithelium and neuroendocrine cells. 
Thus, in the developing lung, a single stem cell has been identified which can 
differentiate into the entire lung epithelium. However, there is no evidence of 
these Id2+ progenitor populations in adult lungs. The field of stem cells in the 
adult lung is still controversial as some believe the region-specific progenitor cell 
model in which the trachea, bronchioles, and alveoli are maintained by distinct 
populations of epithelial progenitor cells (Rawlins et al., 2009b), while others 
believe a model in which the adult mouse lung contains a population of 
multipotent epithelial stem/progenitor cells whose descendants give rise to airway 
and alveolar epithelial cell lineages (Kim et al., 2005; McQualter et al., 2010). 
There are also some studies which demonstrate that bone marrow or umbilical 
cord derived stem cells can regenerate lung epithelium (Neuringer and Randell, 
2004).  
 
Local adult epithelial stem or progenitor cells identified in the lungs are discussed 








Figure 2 : Putative stem cells in the lung 
Basal cells, Clara cells, Bronchioalveolar stem cells and alveolar type II cells have 
been proposed as putative stem or progenitor cell populations in the adult lung. 
Architecture of the lung adapted from Liu et al., 2006. 
 
1.5.1 Clara cells 
As early as 1978, it was speculated that Clara cells can self-renew and give rise to 
ciliated cells in the bronchioles in response to chemical injury (Evans et al., 1978). 
These early reports were supported later by experiments involving selective 
chemical depletion of Clara cells using naphthalene. It was observed that 
Neuroepithelial bodies (NEBs) (Reynolds et al., 2000b), and the bronchioalveolar 
duct junctions (BADJ) (Giangreco et al., 2002) sequester regenerative variant 
Clara cells, which contribute to bronchiolar regeneration. An interesting 
transgenic suicide gene ablation approach was employed to conclude that this 
variant Clara cell is both necessary and sufficient to restore the bronchiolar 
epithelium (Giangreco et al., 2002; Hong et al., 2001; Reynolds et al., 2000b). 
Proliferation and hyperplasia of pulmonary neuroendocrine cells (PNE) cells also 
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occurred in this system (Reynolds et al., 2000a) but they were unable to 
repopulate the ablated epithelium (Hong et al., 2001). More recently, the 
Scgb1a1-CreERTM transgenic mouse was used to clearly demonstrate that in the 
post-natal lung, majority of Clara cells could self renew in the trachea and 
bronchioles and also differentiate into ciliated cells (Rawlins et al., 2009b). 
 
1.5.2 Bronchioalveolar stem cell 
Bronchioalveolar stem cells (BASCs) were first identified in a lung tumor model 
study by (Jackson et al., 2001) in which a Lox–Stop–Lox-K-ras conditional 
mouse strain (referred to as LSL-K-ras G12D) was used to develop lung tumors. 
Expression of oncogenic K-ras was induced in this model by administration of 
AdenoCre virus into the lungs which removed the floxed stop element. This 
model gave rise to adenocarcinomas which contained a population of unique 
double positive cells (CC10+ SPC+) suggesting their role in tumor initiation. Kim 
and colleagues (Kim et al., 2005) further illustrated that these cells, renamed as 
Bronchioalveolar stem cells or BASCs were observed in the normal mouse lungs 
at the bronchioalveolar duct junction. BASCs are resistant to Napthalene and 
bleomycin injuries and also proliferate in vivo in response to these injuries. 
BASCs were characterized as Sca-1pos CD45neg Pecamneg CD34pos cells and have 
tumor initiation potential as well as stem cell properties like self-renewal and 
multipotent differentiation to CC10+ and SPC+ cell types in vitro. These studies 
suggested their possible stem cell potential to regenerate the distal airways 
including the terminal bronchioles and the alveolar epithelium. Subsequent 
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studies illustrate the importance of Bmi1 for the self-renewal of these BASCs 
(Dovey et al., 2008; Zacharek et al., 2011). However the BASCs theory is not 
supported by single cell cloning assays, transplantation studies or lineage tracing 
experiments. Further, Rawlins and colleagues (Rawlins et al., 2009b) conducted 
lineage tracing experiments using a CC10 driven reporter system to clearly 
demonstrate that there is no special function of the BASCs cell population during 
postnatal growth, adult homeostasis, or repair. 
 
1.5.3 c-kit+ stem cells 
Kajstura and colleagues (Kajstura et al., 2011) recently reported a pool of resident 
multipotent cells in the human lung with stem cell potentials including self-
renewal, clonogenicity, and multipotentiality in vitro. In vivo, these c-kit+ cells 
had the ability of creating human bronchioles, alveoli, and pulmonary vessels in 
immunosuppressant mice after cryo-injury. Their long term proliferation and self-
renewal potential was also illustrated in serial-transplantation assays. This 
research has opened up a whole new avenue in the stem cell field arguing that 
there is one adult stem cell which can differentiate to cell types of different germ 
layers including epithelial cells of endodermal origin and pulmonary vessels 
derived from the mesoderm (Morrisey and Hogan, 2010). These results will need 
careful validation experiments to confirm the existence of such multipotent adult 




1.5.4 Alveolar type II cells 
There is significant evidence suggesting that alveolar type II cells are the major 
progenitor cell population of the alveolar region and can differentiate to alveolar 
type I cells. Evans and colleagues used a nitrogen dioxide (48 hours of exposure 
to 15-17 ppm NO2) chemical injury model in rats to demonstrate that alveolar 
type II cells may contribute to alveolar type I cell regeneration (Evans et al., 
1973). Tritiated thymidine (3H-TdR), used to label dividing cells was detected in 
alveolar type II cells one hour after injury. The researchers followed the rats for 
several days to show an increase in labeled type I cells population with time thus 
suggesting that alveolar type II cells transform to type I cells. Around the same 
time, Adamson and Bowden reported similar results with the same 3H-TdR 
labeling system in mice exposed to 90% oxygen for 6 days to conclude that 
alveolar type II cells can transform into alveolar type I cells (Adamson and 
Bowden, 1974). Bleomycin injury models analyzed by light and electron 
microscopy as well as phospholipid analysis of the alveolar washings supported 
the hypothesis that alveolar type II cells divide and subsequently transform into 
type I cells during repair (Aso et al., 1976).  
 
1.5.5 Basal cells 
It has long been supposed that, by analogy to epidermal basal cells, basal cells in 
the trachea and bronchi play a pivotal role as stem cells in maintenance of the 
mucociliary epithelium of the upper airways. Back in the 1980s, Inayama and 
colleagues suggested that the basal cells are the major stem cell population of the 
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large airways in rabbits. They used centrifugal elutriation to isolate a majority 
fraction of rabbit basal cells (83-94%) and directly (Inayama et al., 1988) or after 
single cell cloning (Inayama et al., 1989) inoculated them in denuded tracheal 
grafts, which were transplanted in mice. In four weeks a fully differentiated 
epithelium consisting of basal cells, secretory cells, goblet cells and ciliated cells 
was obtained in these grafts. These studies were also supported by a numerous 
3H-TdR labeling studies (Breuer et al., 1990) as well as morphometric studies 
(Evans et al., 1990; Evans and Plopper, 1988). Johnson and colleagues (Johnson 
et al., 1990a; Johnson et al., 1990b) used flow cytometry of rat tracheal cells to 
separate small, agranular cells (basal cells) from large, granular cells (secretory 
cells), and suggested that secretory cells are highly proliferative and multipotent 
whereas basal cells are more restricted in their ability to grow and differentiate.  
 
Although these data were suggestive of a possible stem cell potential of basal 
cells, the above experiments were conducted based on rather non reliable 
parameters to identify basal cells including cell density, size, and granularity for 
cell. Secondly, a big problem in the field was the absence of functionally 
important unique markers which could be used to identify different populations of 
cells. Randell et al., 1991, used two biochemical markers, namely cell surface -
galactosyl end groups detected with a lectin from Griffonia (bandeiraea) 
simplicifolia (GS I) and secondly, the keratin 14-related protein using monoclonal 
antibodies. The GS I-negative fraction had a lower colony-forming efficiency 
than the GS I-positive fraction but, it too, was able to repopulate denuded tracheal 
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grafts with a complete mucociliary epithelium. These results show that both GS I-
positive and -negative cells had the potential to proliferate and differentiate into 
the major tracheal cell types. Ford and Terzaghi-Howe, 1992a, b, used different 
markers namely Bandeiraea simplicifolia lectin I, isolectin B, (BSI-B4) and Ulex 
europaeus agglutinin 1 (UEA I) lectins to sort out basal cells and secretory cells 
from rats. They observed that only the basal cell population was clonogenic in 
vitro, and when transplanted onto denuded tracheas or segments of inverted 
intestine, could repopulate the muco-ciliated epithelium. Thus these tracheal graft 
models demonstrated that both basal and secretory cell-enriched cell populations 
have the ability to regenerate a completely stratified muco-ciliary epithelium (Liu 
et al., 1994; Randell et al., 1991). 
 
Researchers also started using chemical injury models such as SO2 or detergent 
treatments in genetic tracing mouse models to demonstrate that basal cells are the 
BrdU label-retaining cells (Borthwick et al., 2001). Finally, Hong and colleagues 
(Hong et al., 2004a, b) illustrated that when all Clara cells are depleted using the 
transgenic suicide gene ablation system following naphthalene injury, the 
Griffonia simplicifolia-IB4, (GSIB4)+ , Keratin 14 (Krt14)+ basal cells are the 
progenitor cell population of bronchial airways. They also performed lineage 
tracing using the Krt14 promoter driver CreERt system to demonstrate that the 
basal cells are capable of either multipotent or unipotent differentiation in vivo to 
restore a fully differentiated tracheo-bronchial epithelium including basal cells, 
ciliated cells, goblet cells and granular secretory cells. 
19 
 
In vitro colony forming assays also demonstrated that Keratin 5 (Krt5) + basal 
cells are capable of forming large colonies in vitro and in the air liquid system can 
differentiate to give Clara cells and ciliated cells (Schoch et al., 2004). Basal cells 
implicated in the regeneration of the tracheobronchial epithelium are positive for 
stratified epithelial stem cell transcription factor p63. p63 is a member of the p53 
family of transcription factors (Yang et al., 1998) and is the master regulator for 
all stratified epithelia including breast, skin, urothelia, and prostrate (Mills et al., 
1999; Senoo et al., 2007; Yang et al., 1999). p63 is expressed in the basal layer of 
the tracheal and bronchial epithelium in the airways. In the p63 knock-out mouse, 
the complete absence of basal cells suggests that p63 is essential for the 
maintenance or survival of the progenitor cell population in the airways (Daniely 
et al., 2004). p63 is also observed in idiopathic pulmonary disorders in human 
samples (Chilosi et al., 2002) and non-small cell lung cancers like squamous 
carcinoma (Massion et al., 2003). Overall, basal cells are believed to be 
progenitor/stem cell populations of the upper airways and are generally identified 
with markers such as p63, Krt5 and Krt14. 
 
1.5.6 Embryonic stem cells 
Along with adult local stem cell populations, researchers have also studied the 
potential of embryonic stem (ES) cells in lung development and regeneration. 
Murine ES cells have been successfully differentiated into alveolar type II cells 
(Ali et al., 2002) and also the tracheobronchial airway epithelium (Coraux et al., 
2005). Recently, human ES cells differentiated in culture into alveolar type II 
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cells improved survival and ameliorated lung inflammation and fibrosis in mice 
with experimentally-induced lung injury. This was the first demonstration that 
cells derived from ESCs can have beneficial effects in lung injury, and it provides 
a platform for potential therapeutic use of ESCs in a variety of lung diseases 
(Wang et al., 2010). 
 
Research on adult stem cells has been growing rapidly and the findings have the 
potential to be applied vastly in regenerative medicine. Adult stem cells have less 
risk of teratoma formation as they are a more committed population (Ronaghi et 
al., 2010). This poses an important advantage for clinical purposes over the use of 
embryonic stem cells or induced pluripotent stem cells (iPS) cells. The lung is a 
vital organ, which is damaged in a variety of diseases and disorders like COPD, 
IPF, ARDS, asthma and lung cancers. In our study, we propose to investigate the 
role of p63+ stem cells in the lung in a physiologically relevant influenza virus 
infection lung injury model that damages both bronchial and alveolar epithelia 
and results in severe form of ARDS. The characterization of these stem cells gives 
us a tremendous opportunity to understand the molecular mechanisms driving 
lung stem cells and to exploit them in developing regenerative therapeutic 





CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Plaque assay 
Plaque assay is a useful technique to measure the concentration of virus or the 
viral titre. A plaque is defined as an area of cells in a monolayer, which display a 
cytopathic effect, observed as white spots when visualized by eye. The plaque 
center may lack cells due to virus-induced lysis. Plaque-forming unit (PFU) is a 
virus or group of viruses which cause a plaque (Dulbecco and Vogt, 1953). 
 
Plaque assay was performed on Madin Darby canine kidney cells (MDCK, ATCC, 
USA). MDCK cells were cultured in high glucose DMEM (Invitrogen, USA) with 
1% L-Glutamine (Gibco, USA), 10% heat inactivated Fetal bovine serum 
(Hyclone Laboratories, INC, USA) and 1% Non-essential Amino Acids (Gibco, 
USA). 3 x 105 MDCK cells were seeded per well of a 24 well plate. Cells were 
incubated for 12-24 hours at 37°C to form confluent monolayer of cells for the 
plaque assay. 
 
Influenza A H1N1 mouse adapted PR/8/34 (vr-95, ATCC, USA) was used for all 
the viral infections. The virus stock was amplified by our collaborator A/Prof. 
Vincent Chow’s lab in chicken eggs. Virus dilutions were made from a range of 
10-1-10-6x. For example, 50µl stock virus + 450µl DMEM medium containing 
1µg/ml TPCK trypsin (Sigma-Aldrich, USA) were mixed together well. This is a 
10-1x dilution of the virus. For serial dilution, 50µl of the 10-1x diluted virus was 
22 
 
added to 450µl DMEM containing 1µg/ml TPCK trypsin. This is a 10-2x dilution. 
The virus was serial diluted until 10-6x in this manner. All virus dilutions were 
made on ice.  
 
A single monolayer of the MDCK cells in 24 well plates was used for the assay. 
After aspirating out the medium and washing the cells with PBS twice, the cells 
were incubated with a range of virus dilutions in 100µl DMEM containing 1µg/ml 
TPCK trypsin for one hour at 37°C. The assay was performed in triplicates for 
each dilution. After the incubation, medium containing the virus was aspirated out 
(and transferred to bleach) and the cells were coated with 1ml of sterilized 1.2% 
Avicel (FMCB biopolymers, USA) in 2x DMEM medium. The plates were then 
incubated in an incubator at 37°C for three days.  
 
After three days the medium containing avicel was aspirated out and cells were 
washed with PBS twice. The cells were then fixed with 4% formaldehyde (Sigma-
Aldrich, USA) in PBS for 20 min and then washed again with PBS twice. The 
wells were then stained with 1% crystal violet (Sigma-Aldrich, USA) in for 20 
min, washed under running water and visualized. The number of plaques 
observed was counted, and the plaque forming unit (pfu) was estimated based on 
the average number of plaques observed for a particular virus dilution. For 
example if three plaques in average were observed in wells containing 100µl of 




2.2 Animal procedures 
C57/Bl6 adult mice (> 6 weeks old) were infected with a sub-lethal dose of 
Influenza H1N1 A/PR/8/34 mouse adapted virus by intratracheal inhalation. Virus 
dilutions were always made in sterile PBS on ice. Mice were anesthetized with IP 
injection of Ketamine (150 mg/kg) + Xylazine (10mg/kg). The anesthetized 
mouse was rested on a stand with its front teeth hung over a suture. This causes 
the mouse airways to be relaxed and accessible. Using flat forceps the tongue of 
the animal was drawn out of its mouth so that the anatomy can be easily 
visualized. For viral infections, intratracheal aspiration was performed by 
pipetting the virus directly into the lungs. 4l/g (of mouse bodyweight) containing 
100pfu virus (diluted in PBS) was introduced into the animal. Sterile PBS 4l/g 
(of mouse bodyweight) was administered to the control animals.  The tongue of 
the mouse was held out and the virus was allowed to aspirate into the lungs.  
 
For bleomycin (Sigma-Aldrich, USA) treatment intratracheal intubation was 
performed. The mouse was positioned on a stand as above and a small cool fiber 
optic light was placed directly under the animal’s throat to illuminate the vocal 
cords. A 1ml syringe (BD biosciences, USA) fitted with a 30G blunt needle (BD 
Biosciences, USA) a 23 Gauge (OD) polyurethane catheter (.012"/0.3mm inner 
diameter and .025"/0.6mm outer diameter, Instech Laboratories, Inc. USA) was 
used to introduce the bleomycin into the animal. The catheter was gently slid 
down along the tongue towards the back of the throat into the trachea of the 
animal. 4l/g (of mouse bodyweight) containing 6U/kg bleomycin in sterile PBS 
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was introduced into the animal. Due to respiration, the solution would enter the 
lungs of the animal. Once the bleomycin was inhaled the catheter was gently 
removed.  
 
The virus or bleomycin treated mice were placed into the cage and monitored for 
distress regularly. Bodyweight of mice were also monitored for kinetics 
experiments after viral infections. If the mice looked very inactive and lost more 
than 20% of their bodyweight they were euthanized. The animals were euthanized 
(increasing concentrations of CO2) and organs were harvested. For BrdU 
incorporation assays, 30 mg/kg BrdU in sterile PBS was administered IP. All 
procedures were conducted under IACUC guidelines and approved protocols. 
 
Mice were euthanized by IACUC approved method of CO2 overdose and tissues 
(lung, skin etc) were harvested. The mice were pinned down and dissected using 
standard procedures. After cutting open the skin and muscle layer the diaphragm 
was carefully cut open without touching the lungs. Once this is done, the lungs 
collapse immediately. For better histology (paraffin embedding only), the lungs 
were re-inflated using fixing solution (4% Formaldehyde in PBS). For lung 
inflation, a small incision was made in the proximal region of the trachea and 
adult lungs were inflated with approximately 1ml of fixing solution using a 30G 
needle. The inflated lungs were held by forceps at the trachea and carefully 
dissected out immediately and transferred to 40ml of fixing solution. Lungs and 
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other tissues were fixed over night at 4°C with gentle rocking and transferred to 
70% ethanol until further processing. 
 
2.3 Tissue/cells processing for cryo-embedding 
Freshly harvested lungs (without inflation) or Matrigel embedded structures were 
embedded in OCT (Tissue-Tek, Japan) on dry ice/liquid nitrogen and placed in -
80 °C. 10µm sections were then cut using a Cryotome (Leica Microsystems, 
Germany) with cryotome blades (Leica Microsystems, Germany) and the sections 
were placed on polylysine coated glass slides (Menzel Glaser, Thermo scientific, 
USA). Slides were stored at -80°C until further use. 
 
2.4 Tissue processing for paraffin embedding 
For paraffin embedding, lungs harvested from mice were inflated with 4% 
formaldehyde in PBS and fixed overnight at 4°C. Formaldehyde fixed tissues in 
cassettes were processed as follows in the Automatic tissue processor (Leica 
Microsystems, Germany). 
Step 1   : 70% ethanol 30 min 
Step 2   : 95% ethanol 15 min 
Step 3   : 95% ethanol 15 min 
Step 4   : 100% ethanol 1 hr 
Step 5   : 100% ethanol 2 hr 
Step 6   : 100% ethanol 2 hr 
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Step 7   : Histoclear 30 min 
Step 8   : Histoclear 30 min 
Step 9   : Histoclear 30 min 
Step 10 : Paraffin vacuum 2 hr 20 min 
Step 11 : Paraffin vacuum 3 hr 
Tissues were then transferred to the Embedding machine (Leica Microsystems, 
Germany) and embedded into paraffin blocks. The blocks were cut using a 
microtome (Leica Microsystems, Germany) fixed with a microtome blade (S35 
Type, Feather, Japan). 5µm sections were cut and transferred to a waterbath set to 
37°C. The sections were flattened out and placed on polylysine coated glass slides 
(Menzel Glaser, Thermo scientific, USA). After draining the water from the slides, 
they were placed on a heating block set at 40°C overnight for drying. Slides were 
then stored at RT until further use. 
 
2.5 Immunocytochemistry on frozen sections 
Frozen sections were fixed with freshly prepared 4% formaldehyde in PBS for 20 
min at RT. After washing away the fixing solution with PBS well (4x, 5min each), 
a PAP pen (Invitrogen, USA) was used to circle each tissue section. For 
Immunohistochemistry (IHC) staining alone, the sections were incubated with 3% 
hydrogen peroxide (Sigma-Aldrich, USA) for 20 min to block the endogenous 
peroxidases and washed away well with PBS (3x, 5min each). The sections were 
blocked and permeabilized with 3% BSA (Sigma-Aldrich, USA) and 0.05% 
TritonX-100 (Sigma-Aldrich, USA) in PBS for 1 hour at RT. For IF staining 
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permeabilization with detergent was avoided. After washing the sections with 
PBS (3x, 5min each), the sections were incubated with respective primary 
antibodies with appropriate dilution (in PBS) for 2 hr at RT or overnight at 4°C. 
The primary antibody was washed out well in PBS, 3x, 10min each on a shaker.  
 
For IF staining, the sections were incubated with Alexa-conjugated secondary 
antibodies (1:300) and 1:500 Hoechst 33342 dye (Invitrogen, USA) in PBS, to 
counterstain nuclei for 1 hr at RT in the dark. After washing the sections well with 
PBS (3x, 10min each), the sections were mounted with Vectashield Mounting 
medium (Vector laboratories, USA) or Antifade (Invitrogen, USA). Cover slips 
were carefully placed on the sections while avoiding bubbles and sealed with nail 
polish. Stained slides were stored at 4 °C in the dark and images were taken using 
Zeiss fluorescence microscope (Observer.Z1, Carl Zeiss, Germany).  
 
For IHC staining, after primary antibody incubation, sections were next incubated 
with biotinylated secondary antibody (1:300 in PBS) from the appropriate Vector 
ABC kit (Vector Laboratories, USA). After 30 min incubation at RT, and washing 
with PBS (3x, 10 min each) the sections were incubated with ABC solution (17µl 
of A and 17µl of B in 1000µl of water) from the same kit. The sections were 
washed well with PBS 3x, 5 min each, and incubated with DAB solution (in 
2.5ml distilled water put 1 drop buffer, 2 drops DAB and 1 drop H2O2, Vector 
laboratories, USA) for 1-3 min. The reaction was stopped with water for 5 min. 
Nuclei were counterstained with hematoxylin (Sigma-Aldrich, USA) for 
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appropriate time (3-5 min) at RT. The slides were immersed in water for 5min 
and then dehydrated in increasing concentrations of ethanol (50%, 70%, 80%, 
90%, and 100%) for 5 min each, and three series of xylene (Sigma-Aldrich, USA) 
for 5 min each. Sections were mounted using Vectamount mounting medium 
(Vector Laboratories, USA) and cover slips were placed on sections while 
avoiding bubbles. The slides were then air-dried and viewed using bright-field 
Zeiss microscope (Imager.Z1, Carl Zeiss, Germany) or Nikon Eclipse TS100 
microscope (Nikon, Japan).  
 
2.6 Immunocytochemistry on paraffin sections 
5µm paraffin sections were first de-paraffinized in series of xylene (10min, 3x 
each) and rehydrated in decreasing concentrations of ethanol (100%, 90%, 80%, 
70% and 50%) for 5 min each. Sections were then washed in PBS briefly and 
antigen retrieval was performed using freshly prepared 10mM sodium citrate, pH 
6 (Dako, Denmark). Sections were heated for 20 min in cooker/microwave with 
the antigen retrieval solution and then cooled down for about 40 min. After briefly 
washing the sections with PBS, the sections were blocked and incubated with 
primary and secondary antibodies following similar protocol as that of frozen 
sections for IF or IHC respectively.  
 
2.7 Primary antibodies 
Antibodies used in this study included influenza virus A M2 protein (ab5416; 
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Abcam, UK), p63, 4A4 clone (Yang et al., 1999), alveolar specific hybridomas 
namely 13A1, 54D1, 11B6 and 1H8 clone; (Kumar et al., 2011), Krt5 (RM-2106; 
Neomarkers, USA, LS-c22715; Lifespan Biosciences, Inc. USA),  actin 
(sc130656; Santa Cruz Biotechnology, Inc. USA), Ecad (sc7870; Santa Cruz 
Biotechnology, Inc. USA), CC10 (sc-9772; Santa Cruz Biotechnology, Inc. USA), 
SPC (sc-7706; Santa Cruz Biotechnology, Inc. USA), Pdpn (sc-134483; Santa 
Cruz Biotechnology, Inc. USA), Aqp5 (sc-9891; Santa Cruz Biotechnology, Inc. 
USA), Cd45 (sc-53665; Santa Cruz Biotechnology, Inc. USA), BrdU (OBT0030; 
Accurate Chemicals, USA), p73 (3A6 clone), Krt14(PRB-155P; Covance, USA), 
Krt6 (ab24646; Abcam, UK), pan-Keratin (c5992; Sigma-Aldrich, USA), SMA 
(A5228; Sigma-Aldrich, USA), acetylated alpha tubulin (T7451; Sigma-Aldrich, 
USA), Ki67 (RM-9106; Neomarkers, USA). Murine monoclonal antibodies were 
generated to rat lung tissue obtained under IRB approval using standard methods 
(Köhler and Milstein, 1975) in the Xian-McKeon lab. 
 
2.8 In vitro culture of mouse and rat lung cells 
Lungs were harvested from mouse or rats and immersed in cold Wash buffer (F12 
(Invitrogen, USA), 1% Pen/Strep (Gibco, USA), 5% FBS (Hyclone Laboratories, 
INC, USA), 50µg/ml Gentamycin (Gibco, USA). The trachea and two main 
bronchi were separated from the lungs and all the five lobes of the lungs were cut 
with a sterile surgical blade (Braun Aesculap Division, Germany) and digested 
with Dissociation Buffer (DMEM, 1mg/ml Pronase (Sigma-Aldrich, USA), 
0.005% Trypsin (Gibco, USA), 10ng/ml Dnase I (Qiagen, Netherlands), 
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1%Pen/Strep, 100µg/ml Gentamycin, and 0.25µg/ml Fungizone (Gibco, USA)) 
overnight at 4°C with gentle rocking. The dissociated cells were then washed well 
with Wash buffer (atleast 4x, 40ml/lung) to remove any traces of the dissociation 
enzyme and passed through 40µm cell strainer (BD Biosciences, USA). The 
single cells are then counted and plated on irradiated 3T3 feeder layers. 
 
3T3 J2 feeder cells (Senoo et al., 2007) were amplified using growth medium 
(DMEM, 10% Bovine calf serum (Hyclone Laboratories, INC, USA), 1% 
Pen/Strep and 1% L Glutamine). Amplified cells were lethally gamma irradiated 
(6000 rads, 1 hour) and evenly plated to form monolayer of irradiated cells.  
 
Dissociated lung cells were plated on the irradiated 3T3 feeder layer and cultured 
in cFAD (Senoo et al., 2007) growth medium (DMEM : F12 - 3:1 (Invitrogen, 
USA), 10% FBS, 1% L-glutamine, 5µg/ml insulin (Sigma-Aldrich, Singapore), 
2x10-9 M 3,3’, 5-Triiodo-L-Thyronine (Sigma-Aldrich, Singapore), 0.4µg/ml 
hydrocortisone (Sigma-Aldrich, Singapore), 10-10 M cholera enterotoxin (MP 
Biomedicals, USA) 10ng/ml epidermal growth factor (Upstate biotechnology, 
Germany), 24 µg/ml adenine (Calbiochem, USA), 1% Pen/Strep). For clonogenic 
assays, lung cells from each mouse (control and infected) were plated in 10 cm 
plates each, and colonies obtained were counted after seven days in culture.  
 
To obtain immature colonies, single cell suspensions of three-week-old mouse 
lungs were plated on 50% growth factor reduced Matrigel (BD Biosciences, USA) 
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coated plates with irradiated 3T3 feeder layers for two passages, 12 days each. 
Differential trypsinization of the fibroblasts and epithelial cells with 0.05% 
trypsin (Gibco, USA) was performed to collect majority p63+ Krt5+ immature 
epithelial stem cells for various assays.  
 
For culture of rat lung epithelial stem cells, rat lungs were dissected similar to that 
of mouse using the following Dissociation buffer (DMEM/F12, 5% FBS, 1% 
Pen/Strep, 0.1mg/ml gentamycin, 2mg/ml, collagenase (Invitrogen , USA)) at 
37°C for one hour with gentle rocking. Rat lung single cells obtained were 
cultured on irradiated 3T3 feeder layer with cFAD medium described earlier. 
Immature colonies were observed from 7-10 days in culture.  
 
2.9 In vitro differentiation of mouse lung stem cells 
Mouse lung cells were cultured on irradiated 3T3 for two passages to obtain p63+ 
Krt5+ colonies. The cells were then differentially trypsinized to obtain the p63+ 
Krt5+ cells and transferred to 8 chamber slides (BD Biosciences, USA) with 50µl 
growth factor reduced Matrigel in growth medium (DMEM/F12, 1:1, 15mM 
HEPES (Gibco, USA), 1% L-glutamine, 1% Pen/Strep, 10µg/ml insulin, 5µg/ml 
transferrin (Lonza BioScience, Singapore), 0.1µg/ml cholera enterotoxin, 25ng/ml 
epidermal growth factor, 30µg/ml bovine pituitary extract (Lonza BioScience, 
Singapore), 5% FBS, 50ng/ml fibroblast growth factor 10 (R&D systems, USA) 
and 30ng/ml hepatocyte growth factor (R&D systems, USA)) for 4 days. 
Differentiation was induced until day 12-15 with differentiation medium 
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(DMEM/ F12, 1:1, 15mM HEPES, 1% L-glutamine, 1% Pen/Strep, 5µg/ml 
insulin, 5µg/ml transferrin, 0.025µg/ml cholera enterotoxin, 5ng/ml epidermal 
growth factor, 30µg/ml bovine pituitary extract, 1mg/ml bovine serum albumin 
(Sigma-Aldrich, USA), 50ng/ml fibroblast growth factor 10 and 30ng/ml 
hepatocyte growth factor). 
 
Medium was changed every alternate day.The structures tend to hollow out by 
day 10-15. For IF of the structures, after 15 days in culture the cells in Matrigel 
were embedded in OCT and placed in -80°C immediately. Cryo-molds containing 
embedded structures were cut using the cryotome and stained for several markers 
using standard procedures. For gene expression analysis structures were 
transferred to Trizol (Invitrogen, USA) after 15 days in culture and used for RNA 
isolation and cDNA conversion. qRT-PCR was performed with primers for 
several genes to study the expression profile of immature and differentiation 
genes. 
 
2.10 In vitro differentiation of rat lung stem cells 
For rat lung cell differentiation, the epithelial cells were cultured as mouse cells 
on irradiated feeder layers and were transferred to 8 chamber slides with 50µl 
growth factor reduced Matrigel in growth medium (cFAD) for 4-5 days and then 
in differentiation medium (DMEM/F12, 15mM HEPES, 1% L-glutamine, 1:1, 1% 
Pen/Strep, 10µg/ml insulin, 5µg/ml transferrin, 0.1µg/ml cholera enterotoxin, 
25ng/ml epidermal growth factor, 30µg/ml bovine pituitary extract, 5% FBS, 
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0.01µM retinoic acid (Sigma-Aldrich, USA)) for 15-20 days. Medium was 
changed every alternate day. For IF of the hollow structures, after 15-20 days in 
culture the cells in Matrigel were embedded in OCT and placed in -80°C 
immediately. The cryo-molds containing embedded structures were cut using the 
cryotome and stained for several markers using standard procedures.  
 
2.11 Immunofluorescence of cells in culture 
For IF staining of cultured cells, medium was aspirated out and cells were washed 
well with PBS. The colonies were then fixed with 4% formaldehyde in PBS for 
20 min at RT. After washing the fixing solution well with PBS, the cells were 
permeabilized and blocked with 0.01% TritonX-100 and 5% FBS for one hour at 
RT. Cells were incubated with primary antibodies with appropriate dilutions in 
PBS overnight at 4°C. After washing the primary antibody away with PBS (3x, 10 
min each), the cells were incubated with Alexa fluor-conjugated secondary 
antibodies with appropriate dilutions in PBS for one hour at RT. The secondary 
antibodies were washed well with PBS (3x, 10 min each), and the nuclei were 
counterstained with Hoechst 33342. Cells were visualized with Zeiss fluorescence 
microscope (Observer.Z1, Carl Zeiss, Germany).  
 
2.12 Histology 
Hematoxylin and Eosin (H&E), the most popular staining technique for histology, 
was performed using standard procedures. Paraffin sections were dewaxed and 
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rehydrated and incubated with Hematoxylin for two minutes and Eosin Y (Sigma-
Aldrich, USA) for 10 seconds. Sections were washed in water for the stain to 
develop. Sections were then dehydrated in series of ethanol and xylene and 
mounted using Vectamount and visualized under light microscope. Hematoxylin 
on oxidation results in haematein that combines with aluminium ions to form the 
active dye-metal complex. The Alum hematoxylin solution imparts a light 
transparent red stain to the nuclei of cells which rapidly turns blue on exposure to 
any neutral or alkaline liquid like water. Eosin is a fluorescent, acidic, red dye and 
binds to basic components of a cell namely, the cytoplasm imparting a pink color 
to the cytoplasm of cells. 
 
Masson Trichrome staining was performed using the Trichrome Stain (Masson) 
Kit (Sigma-Aldrich, USA) following standard kit procedure. The kit involves 
sequential staining of the sections with Biebrich Scarlet-Acid Fuchsin, PTA/PMA 
and Aniline Blue. Nuclei are counterstained purple with hematoxylin, Cytoplasm 
and muscle fibers stain red whereas collagen displays blue coloration.  
 
2.13 Western blot 
Lungs from control or infected mice were homogenized using a hand held 
homogenizer and cells were lysed with Nonidet-P40 (NP40) buffer (150mM NaCl, 
1.0% NP-40, 50mM Tris-HCl pH 8.0, Protease Inhibitors (Roche diagnostics)). 
30g of total protein for each sample was resolved on a 10% SDS polyacrylamide 
gel and transferred to methanol-activated PVDF membranes (GE healthcare). 
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After washing once with TBST (20mM Tris, pH 7.5, 500mM NaCl, 0.1% Tween 
20), the membranes were blocked for 1 hour at RT in 5% bovine serum albumin 
(BSA) in TBST with mild shaking. The blots were then incubated with primary 
antibody at appropriate dilution in TBST with 2% BSA overnight with gentle 
shaking at 4°C, washed thrice for 20 minutes with TBST and incubated with 
horseradish peroxidase-conjugated secondary antibody for 1 hour at room 
temperature. The blots were washed with TBST 3 times for 5 minutes and 
visualized using a chemiluminescent substrate (Luminol reagent, Santa Cruz 
Biotechnologies). 
 
2.14 Quantitative real time polymerase chain reaction  
Total RNA was extracted from cells using Pico pure RNA extraction kit (Arcturus, 
USA) or RNeasy mini kit (Qiagen, Germany) and approximately 1µg RNA was 
converted to cDNA using the High capacity cDNA Reverse transcription kit 
(Applied Biosustems, USA). For primer designing, the cDNA sequences of genes 
from NCBI were imported into the Primer Express 3.0 software (Applied 
Biosystems, USA). Designed primers were tested by PCR using whole lung, 
trachea or skin cDNA. Relative transcript levels of different genes were quantified 
by SYBR green real time PCR (SYBR green PCR Master mix, Applied 
Biosystems, USA) using ABI Prism 7900HT Sequence Detection System 2.2 
(Applied Biosystems, USA). The results were normalized to GAPDH and 
analyzed using SDS 2.2.2 software. The PCR cycle used for all PCR is as follows. 
Step 1: 50°C, 2 min 
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Step 2: 95°C, 10 min 
Step 3: 95°C, 15 sec 
Step 4: 60°C, 1 min 
Step 5: Repeat Steps 3, 4 40x 
 
The primer sequences used in qRT-PCR are as follows: 
Gene Primer sequence (5’->3’) 
Sftpa1 f AGGCAGACATCCACACAGCTT 
Sftpa1 r GCAGGCCTCCAACTTCAGATC 
Sfptb f TGCCCAGGTGCAGCTATCA 
Sfptb r CCAGAATTGAGGGCCTTGTG 
SftpC f GAGCAGACACCATCGCTACCTT 
SftpC r TAGGTTCCTGGAGCTGGCTTAT 
Aqp5 f TTCACCGGCTGTTCCATGA 
Aqp5 r CGATCGGTCCTACCCAGAAG 
Ptgs2 f TGCCTCCCACTCCAGACTAGA 
Ptgs2 r CAGCTCAGTTGAACGCCTTTT 
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Cftr f CAGCTCAAACAACTGGAATCTGA 
Cftr r GCTCGAAGTGTCCAGAGTCCTT 
CC10 f ATTACAACATCACCCCACATCTACA 
CC10 r CTGCAGCAGATGGACAGCAT 
Muc5ac f GGTGTCGGCCGGAGAAA 
Muc5ac r GAGCGGTGTTCATGGTACGA 
Krt10 f CAGCTGGCCCTGAAACAATC 
Krt10 r CACGCAGTAGCGACCTTCTG 
Krt5 f CCCCTCTGAACCTGCAAATC 
Krt5 r TCGATGAAGGAGGCAAACTTG 
Krt14 f ACGAGAAGATGGCGGAGAAG 
Krt14 r CTCTGTCTTGCTGAAGAACCATTC 
Krt6a f TGACCCTGAAGAAGGATGTAGATG 
Krt6a r CTGCCTTGGCTTGCAGTTC 
Vim f GCTGCAGGCCCAGATTCA 
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Vim r TTCATACTGCTGGCGCACAT 
Gapdh f ATCACTGCCACCCAGAAGAC 
Gapdh r CACATTGGGGTAGGAACAC 
 
Table 1 : Primer list for gene set used for in vitro differentiation analysis (Fig. 
20C) 
 
Gene Primer sequence (5’->3’) 
Fabp5 f AACGACAGCTGATGGCAGAA 
Fabp5 r GACCAGGGCACCGTCTTG  
Krt14 f ACGAGAAGATGGCGGAGAAG 
Krt14 r CTCTGTCTTGCTGAAGAACCATTC 
Pthlh f GCCTGGGAAACGCAGAGA 
Pthlh r CCAGGCAGACCGAGTCCTT 
F13a1 f GGTCGCTACCCTCAGGAGAAC 
F13a1 r TTCCGCTTTGCAGCTCTTTC 
Pf4 f CGGTTCCCCAGCTCATAGC 
39 
 
Pf4 r CCGGTCCAGGCAAATTTTC 
F2r f GGCAGTTCGGGTCTGGAAT 
F2r r GGCGTACATGTTCCCGTAAAA 
CD36 f GGACATACTTAGATGTGGAACCCATA 
CD36 r TGTTGACCTGCAGTCGTTTTG 
Acvrl1 f CCCCGAGTGGGTACCAAAA 
Acvrl1 r TCTGTGCGGATGTGCTCATC 
Entpd1 f GTGCGTACCTGGCCGAAT 
Entpd1 r TGATGCTTGGATGTTGGTATCAG 
Acvr1b f CCATGAAAACATCCTTGGCTTT 
Acvr1b r CTGGGTCCAGGTGCCATTAT 
Inhba f ACAAGAGCCGGCTGACAAAA 
Inhba r TAATCCAGCAACTTGCCAACAG 
Mmp9 f CACCTTCACCCGCGTGTAC 
Mmp9 r GCTCCGCGACACCAAACT 
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Krt6a f TGACCCTGAAGAAGGATGTAGATG 
Krt6a r CTGCCTTGGCTTGCAGTTC 
Gapdh f ATCACTGCCACCCAGAAGAC 
Gapdh r CACATTGGGGTAGGAACAC 
 
Table 2 : Primer list for microarray validation of mouse lung colonies 
(Fig.15C) 
 
2.15 Laser capture microdissection 
At 12 or 25 dpi mice were sacrificed and the harvested lungs were embedded in 
OCT and frozen on dry ice immediately to preserve RNA. 10µm cryosections 
were cut and stained with several antibodies including Krt5, SPC, 11B6 using 
standard protocols. Desired regions were marked out and the consecutive four 
sections on membrane slides were stained with Histogene staining solution 
(Arcturus Bioscience, Inc, USA) briefly and then used for LCM with the PALM® 
Robot Microbeam laser microdissection system (P.A.L.M. GmbH, Bernried, 
Germany) using the antibody stained slides as reference. The microdissected cells 
were collected from the adhesive Cap tubes (Carl Zeiss Microimaging GmbH, 
Germany) and used for RNA isolation using the PicoPure RNA Isolation Kit 
(Arcturus Bioscience, Inc, USA).  
 
2.16 Microarray preparation and analysis 
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The RNA Amplification and cDNA conversion was performed using the WT-
OvationTM Pico RNA Amplification System (NuGEN, UK). This system uses the 
Ribo-SPIATM technology, which starts from a minimum of 500pg RNA to get 3-
5µg of cDNA. The sense transcript cDNA (ST-cDNA) was then synthesized 
using the WT-OvationTM Exon Module (NuGEN, UK). The amplified, single-
stranded cDNA was fragmented and labeled for microarray using the FL-
OvationTM cDNA Biotin Module V2 (NuGEN, UK). Fragments and labeled 
cDNA was then hybridized on GeneChip Mouse Exon 1.0 ST Array (Affymetrix, 
USA) using appropriate hybridization controls and the chips were scanned. The 
experiments were conducted in triplicates (each sample was taken from three 
mice lungs). 
 
GeneChip operating software was used to process all the Cel files and calculate 
probe intensity values. To validate sample quality, probe hybridization ratios were 
calculated using Affymetrix Expression Console software. The intensity values 
were log2-transformed and imported into the Partek Genomics Suite 6.5(beta). 
Exons were summarized to genes and a 1-way ANOVA was performed to identify 
differentially expressed genes. p values and fold-change were calculated for each 
analysis. Heatmaps were generated using Pearson’s correlation and Ward’s 
method and Principal Component Analysis was conducted using all probe sets. 
Pathway analyses were performed using Gene Set Enrichment Analysis (GSEA) 




2.17 Genomic DNA extraction and genotyping PCR 
Mice were ear-tagged and tail snips were cut following IACUC protocol and BRC 
SOP for genotyping. Tail snips (< 1cm) were digested at 55°C over night at 800 
rpm shaker speed with 500µl proteinase K digestion buffer (50mM Tris pH 7-8, 
5mM EDTA, 1% SDS, 0.2M NaCl, 200µg/ml proteinase K (Roche Diagnostics, 
USA). After cooling the samples to room temperature, equal volume of 
Phenol/Chloroform/Isoamyl alcohol, 25:24:1 (Sigma-Aldrich, Singapore) was 
added to each tube and samples were vortexed well (30 sec). Samples were spun 
down at 13,200 rpm for 10 min to separate out the organic and inorganic phases. 
The DNA from the top phase was transferred to a new tube while avoiding the 
interface contamination. Two volumes of 95% ethanol was added to the DNA and 
the tubes were vortexed and spun down at 13,200 rpm for 5 min to precipitate out 
the DNA. The DNA pellet was washed with 70% ethanol once and after air-
drying the tubes to ensure complete removal of ethanol, the DNA pellet was re-
suspended in 100µl water. 1µl of this sample containing a range of 50-100ng of 
DNA was used for genotyping PCR. 
 
ROSA –LACZ mice were genotyped using the “Gt(ROSA)26Sortm1sor STD” 
protocol from Jackson Laboratories. Primers used for the PCR are as follows 
Primer 1: 5’-GCG AAG AGT TTG TCC TCA ACC-3’ 
Primer 2: 5’-AAA GTC GCT CTG AGT TGT TAT-3’ 
Primer 3: 5’-GGA GCG GGA GAA ATG GAT ATG-3’ 
Expected band size: Mutant = 340 bp, Heterozygote = 340 bp and 650 bp, 
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Wild type = 650 bp. 
 
Krt14 CreERt2 mice were genotyped using the 
“Gt(ROSA)26Sortm1(cre/Esr1)Nat” protocol from Jackson Laboratories. Primers 
used for the PCR are as follows 
Transgene forward : 5’-GCG GTC TGG CAG TAA AAA CTA TC-3’ 
Transgene reverse  : 5’-GTG AAA CAG CAT TGC TGT CAC TT-3’ 
Wildtype forward   : 5’-CGT GAT CTG CAA CTC CAG TC-3’ 
Wildtype reverse    : 5’-GGA GCG GGA GAA ATG GAT ATG-3’ 
Expected band size: Mutant = ~102 bp, Heterozygote = ~102 bp and ~400 bp, 
Wild type = ~400 bp. 
 
Genotyping PCRs were performed using the Titanium Taq Polymerase enzyme 
and buffer (Clonetech Laboratories, Inc. USA), 10mM dNTP and 10µM primer 
mix. The PCR cycle used was as follows.  
Step 1: 95°C, 3min 
Step 2: 95°C, 30 sec 
Step 3: 68°C, 1 min 
Step 4: Repeat steps 2,3 for 30 cycles 
Step 5: 68°C, 5min 
Step 6: 10°C, hold 
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Samples were loaded on 2% agarose (Invitrogen, USA) gel with 1kb plus ladder 
(Invitrogen, USA) and visualized using a gel documentation machine (Syngene, 
USA). 
 
2.18 X-gal staining of mouse lungs 
Krt14CreERt2 x Rosa-STOP-Lacz mice were infected with a sub-lethal dose of 
influenza virus and treated with IP injections of 200mg/kg tamoxifen (Sigma-
Aldrich, USA) dissolved in corn oil (Sigma-Aldrich, USA), at 5, 6 and 7 dpi. The 
mice were monitored regularly and sacrificed at 25 dpi. Mice were dissected and 
lungs were inflated with 1ml cold fixing solution (4% formaldehyde in PBS). The 
inflated lungs were incubated in fixing solution on ice for 20 min for the initial 
fixation of the tissue. After brief fixing, the lungs were washed in PBS two times, 
and reinflated with Wash buffer (0.2% NP-40, 0.01% sodium deoxycholate, 2mM 
MgCl2 in PBS). The lungs were then washed in Wash buffer for 30 min, three 
times each to ensure the formaldehyde was washed off completely. Any remains 
of fixing solution will interfere with the X-gal enzymatic reaction. The lungs were 
then placed in the freshly prepared Staining solution (25mM Potassium 
ferricyanide, 25mM Potassium ferrocyanide, 1mg/ml X-gal (Invitrogen, USA) in 
Wash buffer) for up to 48 hours at 4°C in dark with gentle rocking. The lungs 
were then washed in PBS three times to wash away the Staining solution and 
fixed over night at 4°C in fixing solution. The lungs were then transferred to 70% 
ethanol and visualized for any blue color from the  galactosidase enzymatic 
reaction. Whole mount images of the tissues were taken using dissection 
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microscope (Leica Microsystems, Germany). Skin from the same mice was used 
as positive control to confirm that the mice were of the correct genotype as Krt14 
is robustly expressed in the basal layer of the skin. Tail from Rosa-lacZ mice, 
which constitutively express  galactosidase was used as a positive control for the 
lacZ staining. Tissues were embedded in paraffin blocks and stained using 
standard procedures mentioned earlier. Histoclear (National diagnostics, USA) 
was used instead of xylene in the dewaxing steps to maintain the blue color 

















CHAPTER 3: INFLUENZA INFECTION MODEL OF LUNG DAMAGE 
AND IDENTIFICATION OF p63+ Krt5+ PODS DURING REPAIR 
 
3.1 INTRODUCTION 
Studies conducted in humans have provided detailed, descriptive information 
about the onset and progression of both inflammatory and physical changes in the 
lungs in disease conditions. This has led to various hypotheses about mechanisms 
of injury, which are difficult to test in humans in clinical settings due to the large 
number of clinical variables. An ideal animal model would reproduce the 
mechanisms and consequences of the human disease thus providing a bridge 
between clinical patient studies and the laboratory set up. These animal models 
provide an excellent platform to investigate as well as validate important 
hypothesis to understand human diseases better. There are small but potentially 
important differences between human and animal airway models on several issues 
such as variation in airway architecture, animal size, and factors of the immune 
system including Toll like receptors, mononuclear phagocyte system and 
chemokine signaling pathways (Matute-Bello et al., 2008). Extrapolation of data 
obtained from mouse models to the human disease system should be done with 
caution to account for these differences. Nevertheless mouse models have 





In the past, several chemical injury models have been used to study lung damage 
and repair. These include oxidizing pollutants such as NO2, O3 (Evans et al., 
1978; Evans et al., 1976), reducing pollutants such as l,l-Dichloroethylene 
(Forkert and Reynolds, 1982), 3-methylfuran (Haschek et al., 1984), SO2 (Kavet 
and Brain, 1974; Lamb and Reid, 1968) and Naphthalene (Mahvi et al., 1977; 
Stripp et al., 1995). Bleomycin is a well established model for induced fibrosis in 
the lungs (Grande et al., 1998). 
 
Influenza induced ARDS has lead to devastating pandemics causing millions of 
deaths worldwide. Animal models have been used in the past to study the immune 
response including viremia and pathogenicity post influenza virus infection (Mori 
et al., 1995). Mouse infection systems have also been utilized to test the efficiency 
of antiviral drugs such as Zanamivir as potential treatment for pandemic causing 
strains such as H5N1 Influenza virus A/HongKong/156/97 (Gubareva et al., 1998). 
Vaccine development against highly virulent vial strains of influenza also require 
preliminary studies in mice (Lu et al., 1999). In our study we use influenza virus 
infection as a physiologically relevant model of lung damage to explore the 
potential stem cell regeneration post infection. Mouse adapted H1N1 Influenza 
A/PR/8/34 strain (Narasaraju et al., 2010) which was originally isolated from a 
patient in Puerto Rico in 1934 (Vr-95, ATCC) was used for all our studies. 
C57/Bl6, a common inbred strain of laboratory mice were used for all 
experiments unless otherwise specified. This chapter describes the various 
parameters considered to establish an influenza virus infection lung damage and 
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repair model as well as the kinetics of the damage and repair process. It has been 
reported that some human influenza viruses can infect mouse lung epithelial cells 
(Ibricevic et al., 2006). We investigate the epithelial damage in mouse lungs post 
influenza virus infection and also report the first observation and characterization 
of p63+ Krt5+ cells during repair in the lungs post infection.  
 
3.2 RESULTS 
3.2.1 Optimization of parameters of viral infection to study lung damage 
and repair 
The first step to establish the model of viral infection was to determine the 
optimal route of viral administration. Several routes of infection were tested with 
a colored dye to determine the route of infection which could best deliver most of 
the dye to all lobes of the lungs. The distribution of the dye to the distal airways 
was important to study damage and repair of upper as well as lower airways. 
Amongst several routes of delivery including intra nasal infection and 
intratracheal instillation, intratracheal aspiration (Fig. 3A) resulted in the best 
distribution of colored dye such as crystal violet (Fig. 3B). We also confirmed no 
aspiration of liquid in the stomach through the esophagus (data not shown).  
 
After establishing the route of infection that would ensure efficient delivery of the 
virus to the lungs, we determined the dose of virus to be used for our study. The 





Figure 3 : Route of infection in mice and viral titer estimation 
A. Intratracheal aspiration of H1N1 Influenza A/PR/34/8 virus. B. Image of 
rodent lungs after intratracheal aspiration with crystal violet dye. C. 
Representative image of plaque assay for H1N1 PR8 virus. An average of three 
plaques was counted in the three wells of 10-4 diluted virus. Thus the viral titer 




the animal alive and able to recover and study the process of lung repair. Bearing 
this in mind, the sub-lethal dose or LD-50 of the virus, which is the dose of virus, 
at which at least half the mice survive the infection was first determined.  
 
Plaque assay was performed to estimate the concentration of the virus stock. Fig. 
3C represents an image of the plaque assay results using H1N1 stock virus. Since 
there are in average 3 plaques/well with 10-4 dilution of the virus, the 
concentration of the stock virus was calculated to be 3x104 pfu/100µl. Knowing 
this initial virus concentration, we infected mice with a range of viral titers 
including 105pfu, 104 pfu, 103 pfu, 500 pfu, 250 pfu and 125 pfu to determine the 
LD-50. All virus dilutions were made in cold sterile PBS and the mock infected or 
control mice were always administered with PBS. 5 mice were used for each viral 
titer and they were monitored for survival until 23 dpi. As expected, at higher 
viral titers of 105-103 pfu all mice died within 6-12 dpi (Fig. 4A, upper panel). 500 
pfu was determined to be the LD50 at which about 50% of the mice survived and 
at 250 and 125 pfu all mice survived (Fig. 4A, lower panel). 
 
After determining the LD50 the next step was to ensure the mice fall sick with the 
low doses of virus infection. The “gold-standard” for evaluating morbidity in 
murine models of viral disease including influenza, is measuring the percentage of 
body weight lost during the course of infection (Mozdzanowska et al., 2005; van 
der Laan et al., 2008). Though the correlation of weight loss with the extent of 




Figure 4 : Survival percentage and body weight kinetics 
A. Mice were infected with a range of viral tires from 105pfu-103pfu (upper panel) 
and 500, 250,125 pfu (lower panel). Five mice were infected for each group 
including the mock infected group (PBS control). The mice were monitored for 
survival and % survival was plotted. B. Body weights of mice infected with 500, 
250 and 125 pfu were tracked until 21 dpi and plotted. 5 mice per group were 
used for the analysis. 
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bodyweight has been used as a rough indication of animal injury and recovery. 
We analyzed the body weights of the mice periodically from 0-23 dpi. It was 
observed that at all three viral titers (500, 250 and 125 pfu) the mice lost at least 
20% of their bodyweight (Fig. 4B). The maximum weight loss occurred between 
9-12 dpi after which the mice started to regain their bodyweight and approached 
normal bodyweight by 23 dpi. This trend in bodyweight suggested that the mice 
fall sick post infection and also recover. In summary, from the survival percentage 
and bodyweight kinetics experiments, it was observed that at 250 pfu all the mice 
survived while still exhibiting significant loss of bodyweight. Hence a dose of 250 
pfu was chosen for future infections. 
 
Viruses used in all our experiments were propagated in chicken eggs in our 
collaborator’s lab (A/Prof. Vincent Chow, NUS). To account for the variation of 
viral titer and virulence from each egg, the above mentioned experiments had to 
be repeated for each new batch of virus (from each egg) to identify the 
appropriate dose for our study.  
 
3.2.2 H1N1 Influenza infection causes damage to mouse lung epithelium 
Bodyweight kinetics studies were indicative of the mice falling sick post infection 
but were not conclusive of actual lung damage. Hence, we infected mice with 250 
pfu of virus and sacrificed them at different time points post infection to harvest 
the lungs for histological analysis. From body weight kinetics studies it was 
observed that the mice lost most of their body weight around 9-12 dpi (Fig. 4B).  
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When we sacrificed mice at 11 dpi, it was observed that the infected lungs 
(without inflation) showed high degree of damage with hemorrhages and 
pulmonary edema compared to the lungs of normal, mock-infected mouse lungs 
(without inflation), (Fig. 5A).  
 
To analyze the viral load in the lungs we used an Influenza A specific marker, M2, 
a viral proton-selective ion channel protein involved in virus assembly (Rossman 
et al., 2010; Wang et al., 1995). As seen in Fig. 5D, left panel, maximum viral 
load was observed at 4 dpi. Moreover, the viral staining was clearly observed in 
the alveolar region as well as in the bronchial epithelium 4 dpi. According to 
literature (Miao et al., 2010), the virus first encounters the innate immune 
response and by 5 dpi the adaptive immune response is induced. Correspondingly, 
a decrease in viral load was observed at 7 dpi when the adaptive immune response 
is active. By 11 dpi the viral load was very low and by 21 dpi the virus was 
completely cleared. This trend of viral staining is very similar to results obtained 
by Verhoeven and colleagues (Verhoeven et al., 2009) who demonstrated that 
even during infections with very high viral titers they were cleared completely by 
12 dpi, indicated by lack of plaque forming units, confirming the absence of any 
replicating virions after 12 dpi.  
 
We also analyzed the histology of the lungs at various time points post infection. 
Fig. 5D, right panel, shows lungs with clear alveolar spaces at 0 dpi. By 4 dpi an 





Figure 5 : Viral infection and kinetics 
A. Representative image of damaged lungs 11 dpi infected with sub-lethal dose of 
H1N1 virus compared to mock infected (PBS) lungs. B. Pictorial representation 
of the trend of viral load and damage after a sub-lethal infection. Maximum viral 
load and maximum lung damage are estimated to be at 4 dpi and 11 dpi 
respectively. C. CD45 IF staining at 0, 11 and 21dpi infection showing an 
increase in immune cell population at 11 dpi. Scale bar represents 100µm. D. 
Image on next page. Left panel demonstrates the viral load in the lungs with IF 
staining for viral ion channel protein M2 (red) at 0 dpi, 4 dpi, 7 dpi, 11 and 21 dpi. 
Right panel depicts histology of the lungs at various time points post infection. 















dpi a massive infiltration of immune cells accompanied with lung consolidation 
was observed. By 21 dpi however, the lungs looked relatively normal again. 
These histological results mirrored the body weight kinetics studies that indicated 
maximum damage in the lungs from 9-12 dpi and recovery nearing 21 dpi (Fig. 
5B,D). 
 
Influenza virus is controlled by both the innate and cell- mediated adaptive 
immune responses (Doherty et al., 2006; Thomas et al., 2006) and the infiltration 
of immune cells was further confirmed by using pan immune cell marker CD45 to 
stain sections at various time points post infection. Fig. 5C represents images of 
frozen sections of lung demonstrating a massive influx of immune cells at 11 dpi 
(middle panel) compared to normal lungs (left panel). Bronchus-associated 
lymphoid tissue or BALT (Sminia et al., 1989) which is commonly observed post 
influenza infection (Moyron-Quiroz et al., 2004) was also observed 21 dpi in 
mouse lungs as detected by CD45 positive staining in large regions of cells 
associated with a bronchus (right panel).  
 
After observing viral load and corresponding immune responses by lung 
pathology, the possibility of epithelial cell damage was investigated. We probed 
for epithelial cell types of upper (Clara and ciliated cells) as well as the lower 
airways (alveolar type II cells) at 7 dpi compared to control (Fig. 6A). Clara cells 




Figure 6 : Epithelial cell damage post H1N1 infection 
A. IF staining of Clara cells (CC10, red) ciliated cells ( tubulin IV, green; 
TAp73, red) and alveolar type II (SPC, red) cells in mock infected and viral 
infected lungs 7 dpi. Scale bar represents 50µm. B. Upper panel shows co-
staining of Clara cell marker CC10 (green) with viral ion channel protein M2 
(red) at 7 dpi. Lower panel depicts co-staining of alveolar type II cell marker SPC 






intact and distributed along the bronchial epithelium in normal mouse lung. 
However by 7 dpi there was widespread loss of marker expression of CC10 as 
well as  tubulin IV and Tap73. Similarly in the lower airways there was a loss of 
alveolar type II cell marker SPC, suggesting damage to these epithelial cell types 
of upper and lower airways.  
 
To further prove the viral infection in these epithelial cell types, we co-stained 
Clara cells and alveolar type II cells with viral M2 ion channel protein markers. 
High magnification images of Clara cells and alveolar type II cells co-stained with 
viral marker revealed that the H1N1 influenza virus used in our experiments can 
infect epithelial cells thus directly or indirectly resulting in epithelial cell damage 
in addition to the substantial immune response elicited post infection (Fig.6B).  
 
3.2.3 Increase in p63 expression during repair 
p63 expression in the normal mouse lungs is restricted to the basal layer of the 
tracheobronchial epithelium (Fig. 7A). (Inset depicts a higher magnification of 
p63 nuclear staining in the basal layer). To examine if p63 plays a role during the 
damage and repair process, we next monitored the total expression level of p63 
post influenza infection. Mice were infected with a sub-lethal dose of influenza 
virus and sacrificed at 7, 11 and 21 dpi. Protein from the entire lungs of mice was 
collected and western blot was performed for p63 using the monoclonal 4A4 




Figure 7 : Increase in p63 expression during repair 
A. IF staining of p63 (red) expression in adult mouse lung. Inset shows higher 
magnification of p63 staining in bronchial epithelium. B. Western blot of p63 
with whole lung lysate at 0, 7, 11 and 21 dpi. Actin was used as loading control 
(left panel). Right panel depicts the quantification of the band densities to 







lungs (0dpi), (Fig. 7B). This was expected as p63 expression is restricted to the 
few basal cells lining the bronchial epithelium in the normal mouse lungs. After 
infection, levels of p63 protein expression increased and reached a maximum 
around 11 dpi. However by 21 dpi, which is the later recovery stages of the 
infection, the expression levels were near normal again. The density of the p63 
bands normalized to the actin loading controls were quantified to further 
substantiate the elevated p63 expression levels at 11 dpi (Fig. 7B, right panel).  
 
Once we established an increase in p63 expression during the damage and repair 
phase post infection, we wanted to localize the p63+ cells in the lungs. At 0 dpi, 
very few p63+ cells were detected underlying the bronchial epithelium only, and 
their intensity was not very high (Fig. 8A). The normal bronchial and bronchiolar 
epithelium was also lined with intact Clara cells (CC10, cytoplasmic) and ciliated 
cells (not stained here). Post infection, a loss of Clara cells was observed because 
of the viral infection as seen by the reduction of CC10 staining at 7 dpi. 
Corresponding to the loss in CC10 expression for Clara cells, we also detected an 
increase in p63+ cells in the bronchial epithelium (Fig. 8A). By 11 dpi, 
p63+CC10+ cells were observed in the bronchial epithelium illustrating that the 
p63+ basal cells give rise to the CC10+ Clara cells during regeneration of the 
bronchial epithelium. By 21 dpi most of the bronchial epithelium looked intact 
with uniform CC10 expression in bronchi and bronchioles, and p63 expression 




Figure 8 : Localization of p63+ cells in bronchial and damaged alveolar 
region 
A. IF staining of basal cells marked by p63 (red) and Clara cells marked with 
CC10 (green) in bronchioles of lungs at 0, 7, 11 and 21 dpi. Scale bar represents 
20µm. B. IF staining for p63 (red) of influenza infected (left panel) and mock 
infected (right panel) lungs at 11 dpi. Br: bronchi, Al: alveolar region. Dotted line 
marks the separation between bronchial and alveolar regions. Top panel shows 
p63 staining (red) and bottom panel shows nuclear counterstained DAPI staining 
of the same region as the respective top panel. Scale bar represents 20µm. C. Left 
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panel represents quantification of p63+ cells in bronchi and bronchioles at 0 and 
11 dpi. Right panel represents quantification of p63+ cells in alveolar regions 
(deep lung). Error bar represents standard deviation about the mean. ND: Not 
detected. Sections from 3 control and infected mice were used for the 
quantification of p63+ cell number/mm2 of positive staining. 
 
few basal cells lining the bronchial epithelium. Thus Fig. 8A demonstrates that 
p63+ basal cells have the potential to differentiate into Clara cells in the bronchial 
epithelium mirroring the results of lung damage and repair using other chemical 
injury models like Naphthalene (Hong et al., 2004a). 
 
 In Fig. 7B we showed that the maximum expression of p63 was observed at 11 
dpi but when we localized the expression in the bronchial epithelium, a maximum 
expansion of p63+ cells was detected at 7 dpi (Fig. 8A). Since these results did 
not correlate well we then considered if p63+ cells were also localized elsewhere 
in the lung to correspond to the maximum p63 protein expression observed at 11 
dpi. Analyses of lungs at 11 dpi interestingly revealed an appearance of p63+ 
clusters in the damaged alveolar regions or interstitial regions along with the 
increase in p63+ cells in the bronchus and bronchiolar epithelium (Fig. 8B). These 
p63+ cells were not observed in the alveolar regions in mock infected mice.  
 
To quantify the p63+ cells in bronchial and alveolar regions the number of p63+ 
cells /mm2 in the lungs at 11 dpi compared to control (area focusing on positively 
stained regions) were counted. We observed an increase in p63+ cells in bronchial 
epithelium at 11 dpi compared to control (Fig. 8C, left panel) as also seen in the 
Fig. 8A, B. No p63+ cells were detected in the alveolar epithelium in mock 
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infected mice (0 dpi) where as regions of p63+ clusters of cells were observed in 
mouse lungs at 11 dpi (Fig. 8C, right panel).  
 
To characterize these p63+ clusters in the alveolar region further, we sacrificed 
mice at later time points post infection such as 15 dpi and co-stained the p63+ 
clusters with Krt5, another basal cell marker. p63+Krt5+ cells were observed in 
the bronchial epithelium as well as in the alveolar region (Fig. 9A). Krt5 staining 
helped to visualize the p63+ cells as discrete pods in the alveolar region. 
Quantification of p63+ Krt5+ cells at 15 dpi revealed that most of the p63+ cells 
were also Krt5+ (Fig. 9B). Only 0.8% of stained cells were single positive for p63 
while 50.7% of the cells were double positive for p63 and Krt5 and 48.4% cells 
were positive for Krt5 alone. These data point to a probable progression where 
initially at 11 dpi, p63+ Krt5+ cells are seen in the alveolar region. Eventually 
p63 expression is lowered and thus 48.4% of stained cells are only single positive 
for Krt5 with p63 expression very faint or nearly lost in them. Given the robust 
cytoplasmic staining of Krt5 for these p63+ cells, Krt5 was used as a marker for 
all staining at later time points to trace this population of cells even after p63 
expression is decreased or lost. These p63+ Krt5+ cells will be called Krt5+ pods 
for simplicity from here on. We confirmed widespread expression of the Krt5+ 
pods in several mice at 15 dpi (Fig. 9C). Also an important point that will be 
addressed later is that these Krt5+ pods are always associated with a bronchus or a 





Figure 9 : p63+Krt5+ pods in repair of damaged lung 
A. Double staining of mouse lungs 15 dpi with Krt5 (green) and p63 (red). Scale 
bar represents 20µm. Right panel shows high magnification of discreet p63+ 
Krt5+ pods. B. Pie chart represents quantification of p63+ Krt5+ cells at 15 dpi. 
Sections from three mice were used for the quantification. 0.8% of the stained 
cells are p63 single positive (p63 sp, green), 50.7% of the cells are p63 and Krt5 
double positive (Krt5 p63 dp, red) and 48.4% of the stained cells are Krt5 single 
positive (Krt5 sp, blue). C. Low magnification IHC image of Krt5 staining on 






3.2.4 Krt5+ pods are not involved in fibrosis 
Fibrosis is one of the most common adverse outcomes of respiratory diseases 
including pneumonia (Yeldandl and Colby, 1994). To address this issue we 
explored the possibility of Krt5+ pods observed in mouse lungs post infection 
leading to fibrosis. Masson’s trichrome staining is a common technique used to 
demonstrate fibrosis and stains red for keratin and muscle fibers, blue for collagen 
and bone, light red or pink for the cytoplasm, and dark brown to black for cell 
nuclei. Fibrotic collagen fibers are commonly observed as blue color in fibrotic 
lungs (Yu et al., 2001). Masson’s trichrome staining in normal lung, stains all 
epithelial cells in bronchial and alveolar regions red while the cartilage and 
connective tissue surrounding the bronchus stains blue (Fig. 10A, right panel). We 
infected mice with H1N1 and stained the Krt5+ regions with Masson’s trichrome 
stain to check if Krt5+ pods led to fibrotic lesions. Fig. 10A, left panel 
demonstrates Krt5 staining in the lungs at 15 dpi and the middle panel represents 
Masson’s trichrome staining of the same region on a consecutive 5µm section. No 
blue colored collagen fibers were observed in regions of Krt5+ pods thus 
eliminating the possibility that Krt5+ pods lead to fibrosis in mouse lungs post 
H1N1 infection. Further, we also evaluated mouse lung sections at 50 dpi with 
Masson’s trichrome staining and could not detect fibrotic collagen fibers (data not 
shown) suggesting that the system of H1N1 infection is a model for lung damage 






Figure 10 : Krt5+ pods are not involved in fibrosis 
A. Left panel showing staining of Krt5 on mouse lung sections at 15 dpi. Middle 
panel shows Masson trichrome staining of consecutive section at 15 dpi. Right 
panel shows Masson trichrome staining in normal mouse lung. Scale bar 
represents 100µm. B. Top panel demonstrates alveolar type I cell staining with 
PDPN (green) and alveolar type II cells staining with SPC (red) at 0, 6 and 15 dpi 
post bleomycin treatment. Bottom panel shows p63 (red) and Krt5 (green) at 0, 6 










To confirm these results we used the bleomycin model to test if Krt5+ pods are 
visible in mouse lungs using this fibrosis system. Mice were treated with 5U/kg 
bleomycin and lungs were harvested at different time points post treatment. The 
kinetics of bleomycin damage is different from infection, and by 6 days post 
treatment there is damage to the lungs as shown by loss of alveolar type I and type 
II cell markers (Fig.10B, top panel). By 15 dpi most of the regions in the lung 
have regained the marker staining. However during this phase no p63 or Krt5+ 
cells were detected in the alveolar regions suggesting that the repair/fibrosis 
taking place post bleomycin treatment does not involve widespread presence of 
p63 and Krt5+ cells. These data further confirm that p63+Krt5+ pods are not 
involved in fibrosis or repair in mouse lungs post bleomycin treatment.  
 
3.2.5 Characterization of Krt5+ pods 
To characterize the Krt5+ pods observed in the repair process post infection 
Krt5+ pods were co-stained with markers of different cell types. Krt5+ pods are 
not immune cells since they do not co-stain with pan immune cell marker CD45 
(Fig.11A). We also eliminated the possibility that they are smooth muscle cells as 
they did not co-stain with smooth muscle actin (SMA) which stain muscle cells in 
the walls of blood vessels in the lungs (Fig. 11B). When Krt5+ cells were co-
stained with pan-Keratin marker (which stains all epithelial cells) significant 
overlap was observed. Thus we confirm the epithelial nature of Krt5+ pods 




Figure 11 : Characterization of Krt5+ pods 
A. Co-staining of pan immune cell marker CD45 (green) with Krt5 (red) on 
mouse lung frozen sections 15 dpi. B. Co-staining of smooth muscle marker SMA 
(green) with Krt5 (red) on mouse lung sections 15 dpi. C. Co-staining of epithelial 
cell marker pan-keratin (green) with Krt5 (red) on mouse lung sections 15 dpi. 






3.2.6 Krt5+ pods are not BASCs  
p63+Krt5+ cells are known to be stem cells for the upper airways. When they 
were first observed in the alveolar region during repair we wanted to determine if 
these cells have any relation to the recently identified putative stem cell marker of 
the upper and lower airways known as BASCs. These cells normally present at 
the BADJ are identified as CC10+ SPC+ cells (Kim et al., 2005). After infecting 
mice with H1N1 virus we stained lung sections 15 dpi for CC10 and SPC to 
identify BASCs at the BADJ. On the consecutive section, we stained with p63 
and Krt5 to test if there was any overlap between these cell populations. As 
shown in Fig. 12A, no p63 or Krt5 staining was observed in the BADJ where 
CC10 and SPC staining was seen. Similarly, in damaged alveolar regions where 
p63+Krt5+ pods were observed, no significant CC10 and SPC staining was 
detected (Fig. 12B). Thus we conclude that Krt5+ pods are an independent cell 
population and may not be connected to BASCs .   
 
3.3 CONCLUSIONS AND DISCUSSION 
In this chapter we describe a novel physiologically relevant system established to 
study lung damage and repair. We identified the sub-lethal dose of H1N1 virus 
that could cause sufficient lung damage, yet also allow the mice to recover and 
regenerate the lungs. We used body weight studies as well as histological analysis 
to determine the kinetics for the damage and repair process. Further, we also 
showed that the virus is capable of infecting epithelial cells in the lung thus 




Figure 12 : Krt5+ pods are not Bronchio-Alveolar Stem Cells 
A. Left panel shows IF co-staining of CC10 and SPC at a bronchioalveolar duct 
junction 15 dpi. Right panel shows IF staining on a consecutive sections for p63 
(green) and Krt5 (red). B. Left panel shows CC10 and SPC staining in deep lung 
area 15 dpi. Right panel shows p63 (green) and Krt5 (red) staining on consecutive 










reflecting viral pneumonia observed in humans. The advantage of this system 
over other chemical injury models is the ability of the virus to damage epithelial 
cells of the upper and lower airways, thus providing an ideal system to identify 
stem cells for the upper and lower airways.  
 
After establishing the system we evaluated the role of p63+ cells during the repair 
process. We observed that p63+ cells in the bronchial epithelium are involved in 
regenerating the damaged Clara cells, thus restoring the bronchial epithelium 
(confirmed with lineage tracing in Chapter 7). These results mirror chemical 
injury models used in the past, which also demonstrate that p63+ basal cells are 
the stem cells for the upper airways.  
 
In addition to this, we also observed an appearance of p63+ Krt5+ pods in the 
damaged alveolar regions at 11 dpi. These epithelial Krt5+ pods were observed in 
many damaged regions of the lung, and were mostly associated with a bronchus 
or bronchiole. It would be interesting to investigate the damage and repair pattern 
as well as the Krt5+ pods in lungs in response to a wide range of viral doses as 
well as different strains of mice. Moreover, the Krt5+ pods are also observed in 
mice infected with more pathogenic strains of Influenza virus such as the H5N1 
virus (data not shown). Whether these results extend to other strains of Influenza 




We eliminated the possibility that Krt5+ pods could be contributing to fibrosis by 
reporting that our model does not result in fibrosis. We also used a known fibrosis 
model like bleomycin treatment and demonstrated that p63+ Krt5+ pods are not 
observed during the fibrotic process.  
 
Considering that Krt5+ pods are not involved in fibrosis of the lower airways and 
that p63+ cells are the stem cells for the upper airways we next wanted to 
investigate if they were related to any known stem cells of the lower airways. 
BASCs are the only reported stem cells for the alveolar region in mice and we 
confirmed that the Krt5+ pods and BASCs are two mutually exclusive 
populations of cells in the lungs. While the contribution of BASCs in this process 
remains unknown, the widespread presence of epithelial Krt5+ pods in interstitial 
regions in the lung during repair is suggestive of a significant function. In the 








The role of lung epithelial stem cells in maintenance and repair of the adult lung 
is ill defined, and their identity remains contentious because of the lack of definite 
markers for their prospective isolation and the absence of clonogenic assays to 
measure their stem cell potential. A stem cell is defined as a self-renewing cell 
population with the ability to differentiate into one or more cell types. Adult stem 
cells in the airways have the ability to generate highly proliferating transit 
amplifying cells by asymmetric cell division. This ability can be measured using 
an in vitro colony forming efficiency assay (McQualter et al., 2010; Schoch et al., 
2004) or in vivo chemical injury models (Hong et al., 2004a, b). 
 
Reports suggest that Krt5+ cells can differentiate into cells of the 
tracheobronchial epithelium in vitro (Rock et al., 2009; Schoch et al., 2004). 
Further, in vitro differentiation assays also illustrate that BASCs which are Sca-1+ 
CD34+ CD45- Pecam- can form CC10 and SPC+ cells in vitro (Kim et al., 2005) . 
McQualter and colleagues recently suggested that a subpopulation of EpCAM (hi), 
CD49f +, CD104+, CD24 (low) epithelial cells have the capacity for self-renewal 
and their descendants give rise to airway and alveolar epithelial cell lineages in 




While these studies have greatly contributed to our knowledge in the field, several 
key questions remain unanswered. It is still not defined if there is a common 
progenitor in the adult lung that can differentiate to form the bronchial and 
alveolar cell types. In our studies, we propose to culture mouse lung cells on 3T3 
feeder layer to obtain stem cell populations that are capable of self-renewal and in 
vitro differentiation. This culture system was initially developed by Dr. Howard 
Green (Rheinwatd and Green, 1975) to culture human keratinocytes and it was 
first used in the field of regenerative medicine to treat burn patients in 1984 
(Gallico III et al., 1984). Since then, this system has been employed for several 
clinical applications like skin engraftment and corneal epithelial grafting (Nishida 
et al., 2004).  
 
p63+ keratinocytes and thymic epithelial stem cells from human and rats 
respectively have been cultured using this system (Barrandon and Green, 1985; 
Senoo et al., 2007). This in vitro culture system involves growing adult stem cells 
on feeder layers to form colonies which could be picked for expansion, molecular 
analysis, or differentiation assays after obtaining clonogenic cells from lungs. 
Detailed microarray analysis and Gene set enrichment analysis (GSEA), a 
powerful analytical method (Subramanian et al., 2005) was also used for 
interpreting gene expression data to reveal novel markers and pathway for 
potential targeting in various experimental systems. In parallel, in vitro 
differentiation assays were performed to determine the differentiation potential of 
the stem cells.  
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In this chapter we discuss the clonogenic ability of the p63+Krt5+ cells observed 
during repair post infection. We also performed detailed molecular analysis and 
differentiation assays in vitro to predict the fate of these cells and uncover novel 
pathways which could be involved in the regeneration process post infection.  
 
4.2 RESULTS 
4.2.1 p63+ Krt5+ pods proliferate during repair  
From all the kinetics studies for damage and repair, our hypothesis was that from 
11 dpi, when the maximum damage was observed, a repair process should have 
been initiated to regenerate the lung epithelium. This regeneration process would 
be enabled by actively proliferating stem cells. To determine if the p63+ cells we 
observed in the damaged regions were proliferating, we co-stained p63 with 
proliferation marker Ki67 (Fig. 13A). Nearly 30% of the p63+ cells co-stained 
with Ki67 suggesting they were proliferating, while about 40% of the cells 
positively stained in the alveolar region were single positive for Ki67 (Fig.13B). 
A major proportion of these were speculated to be immune cells.  
 
To further confirm the active proliferation of p63+ Krt5+ pods, we performed 
BrdU incorporation assays. After infecting mice with sub-lethal dose of H1N1, 
the mice were injected with BrdU at 11 dpi. Lungs were harvested at several time 
points including several hours post injection at 11 dpi, and also at 15 and 19 dpi. 




Figure 13 : p63+Krt5+ cells are proliferating 
A. IF staining of p63 (green) and Ki67 (red) on mouse lung sections 11 dpi. Scale 
bar represents 20µm. B. Pie chart represents quantification of p63+ Ki67+ cells at 
15 dpi. Sections from three mice were used for the quantification. 30.2% of the 
stained cells are p63 single positive (p63 sp, green), 28.1% of the cells are p63 
and Ki67 double positive (Ki67 p63 dp, red) and 41.7% of the stained cells are 
Ki67 single positive (Krt5 sp, blue). C. Upper panel represents the schematic plan 
for the BrdU pulse chasing experiment. Mice were infected with a sub-lethal dose 
of the H1N1 virus and treated with BrdU at 11 dpi. The mice were then sacrificed 
at different time points including 11, 15 and 19 dpi. Lower panel shows a low 
magnification image of Krt5 (red) and BrdU (green) at 15 dpi. Scale bar 




would be labeled with BrdU. Fig.13C represents an image of proliferating Krt5+ 
cells in bronchial as well as damaged alveolar regions surrounding a bronchus at 
15 dpi, labeled with BrdU. 
 
Next, we quantified the proliferating Krt5+ cells in the bronchial and alveolar 
epithelium. To analyze the percentage of Krt5+ BrdU+ cells amongst the Krt5+  
cells in the bronchial epithelium we co-stained infected lung sections and 
quantified them across 11, 15 and 19 dpi (Fig. 14A). Maximum number of double 
positive cells in the bronchial or bronchiolar epithelium were observed at 11 dpi 
as seen in the representative IF image in the left panel. These data suggest that the 
labeled Krt5+ cells eventually differentiate into other cell types in the bronchial 
epithelium resulting in the decreased number of Krt5+ cells labeled with BrdU at 
later time points (right panel). Interestingly, when we quantified the percentage of 
Krt5+ BrdU+ cells amongst the Krt5+ cells in the alveolar epithelium, we 
observed maximum number of double positive cells at 15 dpi (Fig. 14B). About 
30% of the Krt5+ cells were labeled with BrdU similar to the quantification data 
obtained with Ki67 staining in Fig.13A. This trend observed could be interpreted 
as a population of Krt5+ pods in alveolar region being labeled at 11 dpi which 
expand in number at 15 dpi to give an increase in double positive cells. This trend 
was represented in Fig. 14 C, which showed relatively small regions of Krt5+ 
pods in alveolar regions at 11 dpi, but by 15 dpi the Krt5+ regions were much 




Figure 14 : Quantification of Krt5+ proliferating cells post infection 
A. Left panel shows Krt5 (red) and BrdU (green) staining in bronchial regions of 
the lung 11 dpi. Scale bar represents 20µm. Right panel demonstrates % of Krt5+ 
BrdU+ cells of all the Krt5+ cells in the bronchus region at 11, 15 and 19 dpi. 
Three mice were used for each time point and error bar represents standard 
deviation from the mean. B. Left panel shows Krt5 (red) and BrdU (green) 
staining in damaged alveolar regions of the lung at 15 dpi. Scale bar represents 
20µm. Right panel demonstrates % of Krt5+ BrdU+ cells of all the Krt5+ cells in 
the alveolar region at 11, 15 and 19 dpi. Three mice were used for each time point 
and error bar represents standard deviation from the mean. C. Krt5 (red) and 





differentiate into other cell types, which was reflected in the decreased number of 
Krt5+ BrdU+ cells by 19 dpi. It has to be noted that with many multiplications, 
the BrdU signal is diluted out which could also be responsible for the decreased 
Krt5+BrdU+ cells with time.  
 
4.2.2 Increase in clonogenic cells during repair 
To confirm the presence of stem cell populations during repair, we conducted 
clonogenic assays of the lung cells in vitro post infection. We infected mice with 
sub-lethal dose of H1N1 virus and at 12 dpi, when p63+ Krt5+ proliferating cells 
were observed in the lungs, mice were sacrificed from mock infected and virus 
infected groups to harvest the lungs. Harvesting lungs at 12 dpi also ensured that 
the virus is completely cleared from the lungs, to avoid transferring any live virus 
to the in vitro culture experiments. Single cell suspension of cells from control 
and infected mouse lungs were seeded on irradiated feeder layers (Fig. 15A). 
Colonies first appear after five days in culture and the colony numbers obtained 
from control and infected lungs were counted at seven days. Interestingly, more 
than 20 fold increase in the number of clonogenic cells from infected lungs than 
control lungs was obtained (Fig. 15B). This data supports our hypothesis of stem 





Figure 15 : Increase in clonogenic cell population during repair post H1N1 
infection 
Schematic represents the workflow followed for culturing mouse lung stem cells. 
Irradiated 3T3 cells are plated and the cells are allowed to settle down and form a 
monolayer feeder of cells. Mice (mock or virus infected) are sacrificed and lungs 
are dissociated using enzymatic digestion and the single cell suspension is then 
plated on the feeder layer. Colonies appear from 5-7 days in culture. Colonies can 
be picked and used for gene expression analysis or in vitro differentiation assays. 
B. Graph depicts number of colonies obtained from lungs of control and infected 
mice. Number of mice n=7 and p value<0.05. Error bar represents standard 
deviation from the mean.  
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4.2.3 Gene expression profiling of colonies from infected lung 
Next we examined if the colonies obtained from control and infected mouse lungs 
were the same, or if we could separate them based on their gene expression 
profiles. After confirming the epithelial nature of these colonies by marking the 
cells with Ecad (Fig. 16B), we picked one colony each, from three mock and virus 
infected mouse lungs (Fig. 16A) for whole genome expression analysis. By means 
of unsupervised clustering of all the six colonies it was observed that the control 
and infected lung colonies cluster separately, demonstrating that the cells 
comprising those colonies were indeed different (Fig.16C). The PCA map shown 
in Fig. 16D further illustrates the same finding. The control colonies were very 
uniform and clustered very close together, while the infected colonies were more 
different in whole gene expression profile probably owing to the more dynamic 
state of the cells contributing to the repair post infection. 506 genes were 
differentially expressed in control and infected colonies and most of the genes had 
similar expression profile in the triplicates from control and infected lungs 
(Fig.16E).  
 
We next performed GSEA analysis of the pathways that were differentially 
regulated because of the gene expression profiles from control and infected lung 
colonies . Genes involved in wound healing, tissue development and regulation of 
growth pathways were differentially enriched in the colonies from infected mouse 
lungs compared to control lungs (Fig. 17A). Fig.17B depicts the heat map of 




Figure 16 : Gene expression analysis of colonies from control and infected 
mice 
A. Three colonies picked from control (top panel) and infected mouse lung 
(bottom panel) culture after 12 days in culture. Scale bar represents 200µm. B. 
Ecad (red) IF staining of mouse lung colonies from control and infected mice. C. 
Unsupervised clustering of control and infected lung colonies based on whole 
genome expression profiles. D. PCA analysis of colonies from control mouse 
lungs (red) and infected mouse lungs (blue). E. Heatmap of 506 differentially 





pathways were validated in three different colonies form control and infected 
mouse lungs and significantly different genes (p<0.05) were plotted (Fig. 17C). 
 
Amongst the genes that were up-regulated in lung colonies, Matrix 
metalloproteinase (MMP)-9, a metalloprotease involved in migration was also 
detected. Interestingly, in normal adult lungs, MMP9 is expressed at low levels 
but is significantly elevated in several lung diseases, including asthma, IPF and 
COPD (Atkinson and Senior, 2003). 
 
Other important genes up-regulated in infected compared to control lung colonies 
were Krt14 and Krt6a. Krt14 is another marker for p63 and Krt5+ basal cells and 
will be discussed more in the coming chapters. Krt6a is a keratin reportedly 
involved in wound healing (Wojcik et al., 2000). We noticed that Krt6a was 
highly up-regulated in infected colonies compared to control suggesting their role 
in lung regeneration. Moreover, Krt6a expression level was sufficient to separate 
the colonies derived from infected and control lungs as Krt6a high and low 
colonies respectively (Fig.18A). To validate this result with more number of 
colonies, we picked a total of 24 colonies from three control and infected lungs 
each (Fig.18B). We examined Krt6a expression in each of the 48 colonies and 
observed a statistically significant up-regulation of Krt6a in colonies from 





Figure 17 : Pathway analysis of mouse lung colonies post H1N1 infection 
A. GSEA analysis of colonies from infected vs control colonies. Enrichment score 
(ES) for the wound healing, tissue development and regulation of growth 
pathways are 0.607, 0.585 and 0.464 respectively, p<0.001. B. Expression pattern 
of genes involved in differentially expressed pathways including wound healing, 
tissue development and regulation of growth in control and infected colonies. C. 
Fold change of genes involved in differentially enriched pathways validated by 
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qRT-PCR in three colonies from control and infected lungs. Error bar represents 
standard deviation from mean, p<0.05. 
 
To validate Krt6a expression in vivo we stained normal and infected lung sections. 
Krt6a expression is absent in normal lungs and at 15 dpi is only detected in areas 
that have p63 expression (Fig.18E). About 50% of the p63+ cells co-stained with 
Krt6a at 15 dpi (Fig. 18D), suggesting Krt6a as a novel marker for the Krt5+ pods. 
Given that Krt6a+ cells are involved in wound healing in the skin we speculated 
that these p63+ Krt5+ Krt6a+ cells could also be involved in regenerating the 
lungs. These data also provide a possible link between the in vitro culture studies 
and in vivo infection data suggesting that the Krt6a+ cells that we cloned in vitro 
are the same as the p63+ Krt5+ pods we detected in vivo during the repair period.  
 
Another gene that was up-regulated in colonies from infected lung was the 
transcription factor Sox2. Sox2 is commonly expressed in the bronchial 
epithelium of the mouse lung (Fig. 19C), and is important for cell proliferation 
and differentiation in the upper airways (Tompkins et al., 2011). During repair, 
Sox2 is present in regenerating bronchi as well as the alveolar regions where p63+ 
cells are present (Fig. 19A, B). About 40% of the cells are double positive for p63 
and Sox2 in the alveolar regions (Fig. 19D). Generally Sox2 stains p63+ cells as 
well as the more differentiated cell types that eventually lose p63 expression 15 
dpi. Sox2 is required to maintain a variety of stem cells and is known to play an 
important role in branching morphogenesis and epithelial cell differentiation 




Figure 18 : 18 Krt6a expression pattern in mouse lungs colonies post H1N1 
infection 
A. Unsupervised clustering of control and infected colonies cluster out as Krt6a 
low and Krt6a high colonies respectively. B. Bright field images of 24 single 
colonies picked from control (left panel) and infected lungs (right panel) after 12 
days in culture. C. Relative expression levels of Krt6a in 24 control and infected 
lung colonies by qRT-PCR. Error bar represents SEM. p<0.05. D. Quantification 
of p63+ Krt6a +cells in total stained cells from three mouse lungs 15 dpi. 3% of 
the stained cells are p63 single positive (blue), 48% stained cells are p63 Krt6a 
double positive (red) and 49% cells are Krt6a single positive (green). E. p63 (red) 
and Krt6a (green) staining in normal and infected lungs 15 dpi. Left panel shows 
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absence of p63 and Krt6a staining in alveolar regions of control lungs. Middle 
panel demonstrates absence of Krt6a staining in p63- damaged regions in lungs 15 
dpi. Right panel shows Krt6a staining in regions which have p63+ clusters. Scale 
bar represents 100µm. 
 
reported that over-expression of Sox2 is observed in squamous cell carcinomas 
and some adenocarcinomas in the lung. 
 
4.2.4 In vitro culture and differentiation of mouse lung stem cells  
We have established that during repair in the lungs post infection there is a 
massive increase in clonogenic cells. We also characterized these cells and 
identified novel markers that could be used for further characterization and 
molecular analysis. 
 
The next step in the study was to determine the differentiation potential of the 
p63+ mouse lung stem cells from the lungs in vitro. In the clonogenic assays used 
above, the colonies obtained were quite differentiated because of the inherent 
problems of the culture system, which causes mouse stem cells to differentiate 
instead of staying immature. 
  
In an effort to improve the conditions to obtain p63+ Krt5+ stem cells in culture 
we tested several culture conditions and concluded that Matrigel coating with 
feeder layer provided the best conditions to get p63+ Krt5+ colonies (Fig.20A). 
These colonies obtained from three-week mouse lungs in the second passage (P1) 




Figure 19 : Sox2 expression in mouse lungs 
A.p63 (red) and Sox2 (green) staining in bronchiolar epithelium in lungs 15 dpi. 
Left panel shows overlapped image of p63 and Sox2 double staining while centre 
and right panel show Sox2 and p63 single staining respectively. Scale bar 
represents 50µm. B. p63 (red) and Sox2 (green) staining in alveolar epithelium in 
lungs 15 dpi. Left panel shows overlapped image of p63 and Sox2 double staining 
while centre and right panel show Sox2 and p63 single staining respectively. 
Scale bar represents 50µm. C. Sox2 (green) staining in bronchial epithelium of 
control mouse lungs. Scale bar represents 50µm. D. Quantification of p63+ Sox2+ 
cells in total stained cells from three mouse lungs 15 dpi. 40% of the stained cells 
are p63 single positive (blue), 46% stained cells are p63 Sox2 double positive 
(red) and 14% cells are Sox2 single positive (green).  
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Krt5+ cells. We picked three immature p63+ colonies for gene expression 
analysis and compared them with the gene expression analysis obtained form the 
differentiated colonies obtained from normal mouse lungs (Fig.20B, 16A).  
 
The whole genome unsupervised clustering analysis grouped the differentiated 
and undifferentiated colonies separately (Fig. 20C) with about 3929 genes 
differentially regulated between them (Fig. 20D). For validation, we compared the 
gene expression of stem cell markers like p63, Krt5 and Krt14 in the immature 
colonies obtained from normal lungs compared to the differentiated mouse lung 
colonies and also mouse colonies from other tissues cultured in the Xian-McKeon 
laboratory including brain, ureter, pancreas, kidney and small intestine. Stem cell 
markers like p63, Krt5 and Krt14 were highly enriched in the immature colonies 
from mouse lungs compared to colonies obtained from differentiated colonies 
from mouse lungs as well as colonies from other tissues (Fig. 21A). We also 
confirmed that the differentiation markers like PDPN (alveolar type I cells), SPC 
(alveolar type II cells) and CC10 (Clara cells) were not up-regulated in the stem 
cell colonies confirming their immature status (Fig. 21B). This data also further 
illustrates that the p63+Krt5+ stem cell colonies are not the same as CC10+ SPC+ 
BASCs reported earlier (Kim et al., 2005). 
 
Once we verified the immature status of the p63+Krt5+ colonies cultured, we 
further went on to perform differentiation assays to determine the differentiation 




Figure 20 : Cloning p63+Krt5+ mouse lungs stem cells 
A. High magnification image of p63+Krt5+ colonies colony obtained from three 
week old mouse lungs. Left panel shows bright field images of immature colonies. 
Middle and right panel shows p63 (green) and Krt5 (red) staining overlapped with 
nuclear stain DAPI (right panel). Scale bar represents 50µm. B. Image of colonies 
used for microarray analysis. Top panel represents the differentiated colonies and 
bottom panel represents the three immature (undifferentiated) colonies used for 
microarray analysis. Scale bar represents 200µm. C. Whole genome unsupervised 
clustering analysis of differentiated and immature colonies. D. 3929 differentially 







three-week old mice after two passages on Matrigel coated 3T3 feeder layer. 
Colonies like these were pooled to get sufficient cells for differentiation assays in 
Matrigel. The immature cells were cultured in differentiation medium in Matrigel 
for 12-15 days to form hollow spherical structures (Fig. 22B). For detailed 
analysis, Matrigel with structures were embedded in OCT and 10µm frozen 
sections were cut through them. The hollow structures were single layered 
epithelial structures that stained positive for Ecad (Fig. 22B). Though the 
structures still expressed stem cell markers like Krt14, confirming they arose from 
the p63+Krt5+ immature colonies, they also stained positive for differentiation 
marker Aquaporin 5 (Aqp5). Aqp5 is a mercury-sensitive water channel and is 
expressed in mouse salivary gland acinar cells, lacrimal glands, eyes and alveolar 
type I cells in the airways. Although AQP5 is most commonly used as an alveolar 
type I cell marker it is also detected in alveolar type II cells as well as tracheal and 
bronchial epithelium in mice (Krane et al., 2001; Nielsen et al., 1997). 
 
At the gene expression level we analyzed the expression levels of several 
differentiated cell markers including surfactants released by alveolar or bronchial 
epithelium like Sftpa1, Sftpb, Sftpc, other alveolar markers like Aqp5, Cftr, Ptgs2, 
Clara cell marker (CC10) and Goblet cell marker (Muc5ac), (Fig. 22C). Along 
with the up-regulation of these differentiation markers we also observed a down-
regulation of the stem cell markers like Krt5, Krt14 and Krt6a suggesting that the 
p63+Krt5+ stem cells are capable of differentiating into terminally differentiated 




Figure 21 : Gene expression analysis of mouse stem cells colonies 
A. Top panel represents signal intensity data obtained for p63, Krt5 and Krt14 
form microarray data sets of different colonies including undifferentiated 
(immature) lungs colonies (lung undiff), colonies from brain, ureter, pancreas, 
kidney, small intestine (SI) and differentiated lung colonies (lung diff). Error bar 
represents standard deviation from mean. B. Signal intensity of differentiation 
markers Pdpn, SPC and CC10 from microarray data sets of different colonies 
including undifferentiated (immature) lungs colonies (lung undiff), colonies from 
brain, ureter, pancreas, kidney, small intestine (SI) and differentiated lung 






such as Krt10 confirmed that the p63+Krt5+ were not differentiating into 
squamous cell types. We also evaluated the expression level of endothelial cell 
markers like Vimentin to ensure that the cells retained their epithelial nature on 
differentiation. All expression studies were done in triplicates and normalized to 
GAPDH expression levels in the cells.  
 
In total we conclude that mouse lung stem cells in our culture system are p63 and 
Krt5+ and can be differentiated into epithelial structures with markers of alveolar 
and bronchial cells up-regulated.  
 
4.2.5 In vitro culture and differentiation of rat lung stem cells 
We also cultured lung stem cells from other rodents such as rats. Single cell 
suspension of adult rat lungs was plated on 3T3 feeder layer to obtain immature 
colonies (Fig. 23A) that are positive for stem cell markers such as p63. When 
these cells were transferred to differentiation conditions in Matrigel they formed 
3D spherical structures that hollowed out after differentiation (Fig. 23B). These 
structures stained positive for alveolar markers like 13A1 and 54D1 (Fig. 23C). 
These two markers are hybridomas developed in the Xian-McKeon lab that react 







Figure 22 : Differentiation potential of p63+Krt5+ mouse lung stem cells in 
vitro 
A. Left panel shows low magnification image of immature colony obtained from 
mouse lungs which are positive for stem cell markers p63 (green) and Krt5 (red), 
right panel. Scale bar represents 200µm and 50µm respectively. B. 3D in vitro 
differentiation of p63+ Krt5+ mouse lung stem cells in Matrigel. Top left panel 
shows bright field image of differentiated hollow structures after 12 days in 
differentiation culture. Scale bar represents 50µm. The structures in Matrigel were 
embedded in OCT and 10µm frozen sections were cut and stained for Aqp5 (red, 
top right panel), Ecad (green, bottom left panel), Krt14 (green, bottom right panel) 
on consecutive sections. Scale bar represents 50µm. C. qRT-PCR analysis of 
selected genes in triplicates of stem cells and Matrigel structures.  
 
4.3 CONCLUSIONS AND DISCUSSION 
In this chapter, the stem cell potential of p63+Krt5+ cells was assayed. We 
observed about 30% of the Krt5+ pods were actively proliferating in vivo during 
repair. This pointed to a stem cell potential of the p63+Krt5+ pods and hence, we 
next assayed the clonogenic ability of these cells. Using a system developed by  
 Dr. Howard Green in the 1970s to culture epidermal stem cells, we observed that 
the cells from infected lungs at 12 dpi were 20 fold more clonogenic than the 
control lungs. These cells had a differential gene expression pattern compared to 
colonies from control lungs and were enriched in pathways related to wound 
healing and tissue development.  
 
Several genes including MMP9 and Krt6a were also up-regulated in the colonies 
from infected lungs. MMP9 is important for cellular migration in several tissues, 




Figure 23 : Rat lung stem cell culture and differentiation 
A. Top left panel represents colonies obtained from rat lung on 3T3 feeder layer. 
Scale bar represents 200µm. Top right panel demonstrates p63 (red) staining on 
the immature rat lung colonies. Scale bar represents 25µm B. Differentiation of 
p63+ rat lung colonies in Matrigel after 21 days in culture. Scale bar represents 
100µm. C. The structures in Matrigel were embedded in OCT and 10µm frozen 
sections were cut and stained for 13A1 (red, top panel) and 54D1 (red, bottom 
panel). Scale bar represents 50µm. D. Rat lung sections stained with alveolar 
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markers 13A1 (red) and 54D1 (red) with CC10 (green). Scale bar represents 
50µm. 
 
after tracheal wounding and terminal airway epithelial cells after bleomycin. 
MMP-9 cleaves type IV collagen, and is thus hypothesized to contribute to the 
migration of epithelial cells through basement membranes (Atkinson and Senior, 
2003).  
 
Krt6a has also been studied extensively in stratified epithelia such as the skin and 
oral epithelium (Wojcik et al., 2000; Wong et al., 2000). While the Krt6a knock-
out mouse has no significant developmental defects in the skin or airways, 
delayed wound healing was observed in the skin suggesting the importance of 
Krt6a+ cells in repair. In our studies, Krt6a was up-regulated in the p63+ Krt5+ 
pods in vivo, and also in the colonies obtained from the lungs of infected mice. 
Krt6a expression profile thus provided a crucial link between the in vivo studies 
and in vitro clonogenic cells suggesting that the increase in clonogenic cells post 
infection could be because of the increase in Krt5+ Krt6a+ cells in vivo 12 dpi. 
These data together suggest that the p63+ Krt5+ Krt6a+ pods observed in the lung 
during repair period were actively proliferating and also had  clonogenic ability in 
vitro.  
 
Interestingly, it was also observed that while Krt6a was not detected in the normal 
airways and during repair (post 11 dpi), it was preferentially observed only in the 
interstitial damaged regions expressing p63. Considering Krt6a knock-out mice 
98 
 
do not have severe developmental effects we propose Krt6a to be a novel marker 
specific to Krt5+ pods and could be used for several important studies in the 
future.  
 
After establishing the proliferation capability of the p63+ Krt5+ cells, we assayed 
the differentiation potential of the p63+ Krt5+ cells in vitro. Since the colonies 
obtained from adult mouse lungs were generally differentiated, we developed a 
novel culture system to obtain small populations of p63+ Krt5+ cells from 3-4 
week old mouse lungs. Although the lungs develop even after birth, by 3-4 weeks 
the development is almost complete (Costa et al., 2001). We validated the 
immature state of the cloned cells by up-regulation of stem cell markers like p63, 
Krt5, and Krt14 and down-regulation of differentiated cell markers in these 
immature colonies. We then transferred the p63+ Krt5+ stem cells to a 
differentiation system to obtain hollow spherical epithelial structures that had 
markers of bronchial and alveolar cell types up-regulated. These data suggest a 
multipotent differentiation potential of the p63+ cells into cell types of upper and 
lower airways. We also prove that these cells in the differentiation system do not 
contribute to squamous differentiation.  
 
It has been reported that p63+ Krt5+ stem cells from tracheal epithelium can 
differentiate into cell types of upper airways (Rock et al., 2009), but the ability of 
these cells in the lung to differentiate into alveolar cell types was not known. 
These results were confirmed by cloning lung stem cells from mouse and rat 
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lungs in our system. The cloned p63+ cells from rat lungs also differentiated into 
hollow spheres that stained positive for alveolar specific hybridomas developed in 
the Xian-McKeon lab. These results confirmed that p63+ cells cloned from mouse 
and rat lungs have the potential to differentiate into alveolar cell types. 
This work was strongly supported by Dr. Yuanyu Hu’s work in the Xian-McKeon 
lab (Kumar et al., 2011) on cloning human region specific stem cells. Dr.Hu 
cloned p63+ Krt5+ stem cells from human nasal epithelium, tracheo-bronchial 
epithelium and distal airway epithelium, and after detailed pedigree analysis 
concluded that although these stem cells differ in gene expression profile only by 
a few 100 genes, they have a confirmed fate. The nasal and tracheo-bronchial 
epithelium in different in vitro culture conditions can differentiate into cell types 
of the upper airways or lead to squamous differentiation. However the p63+ 
Krt5+ stem cells from the distal airways have a multipotent ability to give rise to 
cell types of upper and lower airways.  
 
Unlike mouse cells that do not grow very well in this culture system, human cells 
grow well and can be passaged several times while maintaining the immature 
state of the colonies. Although we obtained p63+ Krt5+ cells in mouse culture, 
the clonogenic efficiency was low and they could not be maintained in their 
immature state for more than two passages, thus making it unsuitable for detailed 
self-renewal analysis, as possible with human or rat cells. Efforts are currently 
being made to improve the culture conditions of mouse lung stem cells to enable 
long-term culture and eventually in vivo transplantation experiments. A robust 
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culture condition is also essential for assays to dissect the underlying mechanisms 
involved in stem cell renewal and differentiation of the stem cells.  
 
In total, the in vitro clonogenic and differentiation assays described in this chapter 
revealed the stem cell potential of the p63+ Krt5+ cells observed during repair. 
These cells will be characterized further in vivo in the next chapter, to understand 



















CHAPTER 5: MOLECULAR ANALYSIS OF Krt5+ PODS IN VIVO 
 
5.1 INTRODUCTION 
In a physiologically relevant lung damage system involving H1N1 infection, we 
have identified p63+Krt5+ pods during the repair process. This unique population 
of cells is not detected in normal lungs, or in adverse pathological phenotypes 
such as fibrosis. Moreover, these Krt5+ pods are actively proliferating in vivo and 
have stem cell potential in vitro, in that they are clonogenic and can differentiate 
into multiple cell types in differentiation assays. To characterize and understand 
the potential of these cells further we sought to perform detailed molecular 
analyses of the p63+ Krt5+ pods in vivo. Due to the unavailability of surface 
markers to isolate this population of cells from the entire lung we employed the 
Laser Capture Microdissection (LCM) technique. 
 
LCM is a technique used for isolating pure populations of cells from a 
heterogeneous tissue section, cytological preparation, or live cell culture via direct 
visualization of cells (Bonner et al., 1997; Emmert-Buck et al., 1996). The cells 
obtained by this method can be used for a variety of applications including DNA 
genotyping and loss-of-heterozygosity analysis, RNA transcript profiling, cDNA 
library generation, proteomics discovery and signal-pathway profiling (Espina et 
al., 2006). There are two general classes of laser-capture microdissection: infrared 
capture systems (Bonner et al., 1997; Emmert-Buck et al., 1996) and ultraviolet 
cutting systems (Schütze et al., 1997; Schütze et al., 1998) . In our study we use 
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the PALM® Robot Microbeam laser microdissection system (P.A.L.M. GmbH, 
Bernried, Germany) in combination with a Zeiss microscope. This system applies 
the laser microdissection and pressure catapulting approach which uses an 
ultraviolet laser (UVA) first to circumscribe the region(s) to be excised, and then, 
pulses the sample below the focal plane to catapult it into an inverted microfuge 
tube cap positioned above the sample. For our experiments, the lung could be 
stained, and desired regions were dissected out using this technology. 
 
Gene expression analysis and pathway analysis were performed to determine the 
differentiation tendency of the Krt5+ pods dissected using LCM. The PANTHER 
(Protein ANalysis THrough Evolutionary Relationships) Classification System 
was used for the pathway analysis. This classification system uses a database of 
published scientific experimental evidence and evolutionary relationships to 
predict the functions of genes and classify them based on their functions (Thomas 
et al., 2003). 
 
In this chapter, we discuss the LCM of samples from mouse lung tissue sections 
12 dpi and the gene expression analysis performed on them.  
 
5.2 RESULTS 
5.2.1 Dissection of Krt5+ pods at 12 dpi 
For the molecular analysis of the Krt5+ populations of cells during repair, mouse 
lung sections 12 dpi were stained for Krt5. Krt5+ cells could be classified in two 
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regions namely “Krt5+ interstitial” and “Krt5+ bronchial” regions. Krt5+ 
interstitial regions consist of the Krt5+ pods detected in the interstitial damaged 
areas of the lungs during repair. “Krt5+ bronchus” consists of the bronchi or 
bronchioles lined with Krt5+ cells in the basal layers of the epithelium. Damaged 
interstitial regions as well as bronchi or bronchioles devoid of Krt5 staining were 
also observed on the same sections. These “Krt5-interstital” regions and “Krt5- 
bronchi” or bronchioles served as controls for the molecular analysis (Fig. 24A).  
 
Fig. 24B demonstrates the isolation of a group of just 10-20 cells from the 
alveolar region of a mouse lung section. These dissected cells can be utilized for 
several purposes including RNA isolation for gene expression analysis.  
For the experiment (Fig. 24C), three mice were infected with a sub-lethal dose of 
the virus and sacrificed at 12 dpi. Lungs were harvested and embedded 
immediately in cryo-molds with OCT. Frozen sections were used in this analysis 
instead of formalin fixed paraffin sections to minimize the degradation of RNA in 
the tissues.10µm sections were cut on membrane slides under RNAse free 
conditions. Adjacent sections on normal glass slides were used for Krt5 staining 
to identify the Krt5+ populations of cells. After imaging the regions to be 
dissected, we used consecutive sections on membrane slides for the LCM of the 
desired population of cells (Fig. 25A). Fig. 25B represents dissection of the Krt5+ 
pods and Krt5+ bronchus from mouse lung sections 12 dpi. All four samples were 
collected in triplicates in this manner, and RNA was extracted from them and 




Figure 24 : Krt5+ populations at 12 dpi 
A. Different populations identified in mouse lungs 12 dpi based on Krt5 staining 
on frozen sections namely Krt5+ bronchus (br), Krt5+ interstitial, Krt5- bronchus 
(br) and Krt5- interstitial. B. Demonstration of LCM of alveolar region from 
105 
 
10µm frozen section of lung before and after the LCM. C. Schematic of workflow 
for LCM of Krt5+ pods and control regions for gene expression analysis. 
 
5.2.2 Gene expression analysis of Krt5+ pods 12 dpi 
Microarray analysis revealed that the biological triplicates for all four samples 
clustered to each other in spite of being isolated from three different mice with 
dynamic ongoing repair processes, thus increasing our confidence in the data. The 
Krt5+ bronchus and Krt5- bronchus clustered together, implicating that they were 
very similar in expression patterns (Fig. 26A). However Krt5+ interstitial and 
Krt5-interstitial samples were plotted far away from each other suggesting the 
Krt5+ pods in the interstitial regions to be a unique population of cells. 
Unsupervised clustering of the samples with the significantly differentially 
regulated genes (Fig. 26B) mirrored the PCA map results. Krt5+ bronchus and 
Krt5- bronchus clustered together, with the distance between the clusters being 
very small. Interestingly, although Krt5+ interstitial regions had a very different 
gene expression pattern compared to the other samples by the PCA analysis (Fig. 
26A), they clustered together with the Krt5- interstitial regions rather than the two 
bronchi samples (Fig. 26B). Fig. 26C details the number of differentially 
expressed genes in each sample which are statistically significant. Krt5+ and 
Krt5- bronchi are very similar to each other with an overlap of 1746 genes. Only 
50 and 43 genes are differentially expressed in the Krt5+ and Krt5- bronchi 
respectively. Additionally, while Krt5+ interstitial and Krt5- interstitial regions 
have 1331 genes common they still have 394 and 114 genes respectively, 




Figure 25 : Laser capture microdissection of Krt5+ pods 12 dpi 
A. Left top panel represents Krt5 stained 10µm frozen lung sections of mice 12 
dpi. Left bottom panel represents Krt5 stained 10µm frozen lung sections four 
sections away from the top panel image. The middle and right panel Krt5 stained 
sections are of similar pattern but from two different mice. Scale bar represents 
100µm. B. Top panel represents dissection of Krt5+ interstitial region from mouse 
lung 12 dpi. Bottom panel represents dissection of Krt5+ bronchus from mouse 
lung 12 dpi. Bottom right most panel represents Krt5 staining on adjacent section 








These analyses imply that Krt5+ and Krt5- bronchi are very similar to each other. 
Krt5+ interstitial regions are a unique population of cells with several 
differentially expressed genes, although in total, they are closer in gene 
expression pattern to the Krt5- interstitial regions than the bronchi samples. 
However, this whole genome expression analysis could be misleading as both the 
Krt5+ and Krt5- interstitial regions, have a common contamination of immune 
cell populations. This could cause them to cluster together, rather than to the 
bronchial epithelium. To avoid this bias we analyzed the expression levels of 
selected bronchial and alveolar genes in the two Krt5+ populations, namely the 
Krt5+ interstitial region and Krt5+ bronchial epithelium (Fig. 27A). Several 
alveolar region related genes were up-regulated and bronchial epithelium related 
genes were down-regulated in Krt5+ interstitial regions compared to the Krt5+ 
bronchus. For example, ECM proteins important for cell adhesion in alveolar type 
II cells such as Fn1 and Dpt (Gereke et al., 2007) were up-regulated in Krt5+ 
interstitial regions. Another ECM protein Tnc (Tenascin C) reported as an 
important gene involved in lung development and tissue repair (Roth-Kleiner et 
al., 2004) was also up-regulated in Krt5+ pods. Increased expression of vascular 
endothelium marker Cdh5 (Monvoisin et al., 2006) and CD34, a marker for 
alveolar capillaries (Pusztaszeri et al., 2006) also suggested that the endothelium 
network, which is crucial for alveolar development, is present in Krt5+interstitial 
regions. Interestingly, CD34+ cells in the lungs have also been reported as a stem 
cell population during SARS infection(Chen et al., 2007). Other genes up-




Figure 26 : Gene Expression analysis of Krt5+ pods 12 dpi 
A. PCA map based on whole genome expression of four populations of cells. 
Krt5+ interstitial cells are marked in purple, Krt5+ bronchus cells marked in green, 
Krt5- bronchus marked in blue and Krt5- interstitial marked in red. Each sample 
is represented in triplicates. B. Unsupervised clustering of significantly (p<0.05) 
differentially expressed genes in the 4 cell types. Each cell type is in triplicates. C. 
Venn diagram representing the gene numbers differentially regulated in the four 
populations of cells. 394 genes and 114 genes are high in Krt5+ and Krt5- 
interstitial regions respectively while 1331 genes are common between both the 
regions. 50 genes and 43 genes are high in Krt5+ and Krt5- bronchi respectively 




reported to be important for cell invasion and migration (Castro et al., 2010) and 
is also expressed in alveolar macrophages (Morato-Marques et al., 2011) while 
Sparc is up-regulated in alveolar fibroblasts during pneumonia (Kuhn and Mason, 
1995).  
 
Additionally, several genes that are related to normal alveolar formation were also 
enriched in Krt5+ interstitial areas compared to Krt5+ bronchi. For example, 
Pdgfra is an important component of the PDGF signaling, which is important for 
the formation and compartmentalization of alveoli in lungs (Boström et al., 2002). 
Msn1 is normally localized to the distal epithelium in the airways and has also 
been studied vastly in the airways. Researchers have shown that Msn1 knock-out 
mice have abnormal alveolar architecture, and have more severe lung damage and 
inflammation upon bleomycin treatment (Hashimoto et al., 2008). Another 
example of genes involved in the lower airways could be Fbn1, a matrix 
component of extracellular microfibrils, which is also important for normal 
alveolar septation (Neptune et al., 2003). Along with the up-regulation of several 
alveolar region related genes, we also observed a down-regulation of bronchial 
epithelium related genes in the Krt5+ interstitial regions compared to the Krt5+ 
bronchus. For example, Muc1, a mucous marker for pseudo-stratified epithelium 
in proximal airways (Buisine et al., 1999), as well as other tracheobronchial 
markers such as Retnla (Doherty et al., 2012), are down-regulated in Krt5+ pods. 
Surfactant proteins such as Sftpa1 (Endo and Oka, 1991), and enzymatic proteins 




Figure 27 : Alveolar genes up-regulated in Krt5+ pods at 12 dpi 
A. Ratio of alveolar and bronchus related gene expression between Krt5+ 
interstitial and Krt5+ bronchial epithelium. Error bar represents standard deviation 
from the mean. B. Expression patterns of specific transcription factors, cell 
surface markers, keratin markers and alveolar markers in Krt5+ interstitial and 
Krt5- interstitial regions. Each sample is in triplicates. C. Pathway analysis of 373 
genes enriched in Krt5+ interstitial region. p <0.05. Black bar represents genes 
from the Krt5+ interstitial regions while white bars represent genes from the 







detoxification of toxins in the upper airways are down-regulated in Krt5+pods 
compared to Krt5+ bronchus. Another interesting marker Prom1 or CD133 stains 
hematopoietic stem cells, as well as a subset of bronchial epithelial cells, have 
some stem cell potential in bleomycin damage models (Germano et al., 2009) and 
are also up-regulated in Krt5+ bronchus but not in the Krt5+ interstitial areas. 
Clara cell markers such as Scgb1a1 (Rawlins et al., 2009b), Scgb3a2 (Reynolds et 
al., 2002) as well as Cyp2f2 a member of the Cytochrome p450 family of proteins 
expressed in bronchial epithelium (Fanucchi et al., 1997) are down-regulated in 
Krt5+ interstitial regions. Ciliated cell related genes including Enkur (Ross et al., 
2007), Dynlrb2 (Geremek et al., 2011), Spa17 (McClintock et al., 2008), Sntn 
(Kubo et al., 2008) are also up-regulated only in Krt5+ bronchus but not in the 
Krt5+ interstitial areas. In summary, an up-regulation of alveolar related genes 
and down-regulation of bronchial epithelium related genes was observed in Krt5+ 
pods.  
 
We next compared the Krt5+ and Krt5- interstitial regions to identify important 
genes under several categories that could be important markers for future studies 
(Fig. 27B). Interestingly, we saw an up-regulation of alveolar type I marker Pdpn 
in the Krt5+ interstitial area compared to the Krt5- regions. In addition, we 
observed an enrichment of Tnc in these Krt5+ regions. As mentioned earlier, Tnc 
is an ECM glycoprotein not expressed in normal adult lung, but is important for 
branching morphogenesis and is expressed at the tips of the newly forming septa 
during the alveolarization phase of lung development (Roth-Kleiner et al., 2004). 
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Zfp52, a gene involved in the lung bud formation in development (Millien et al., 
2008) was also up-regulated in Krt5+ interstitial regions compared to Krt5- 
interstitial region. Several surface markers including Cd34, Cd44, Cd24a, Cd9, 
Itgb4 and Keratin markers like Krt5, Krt14, Krt6a, Krt19 and Krt20 were also 
enriched in the Krt5+ regions.  
 
Transcription factors up-regulated in the Krt5+ interstitial regions include p63, 
Ehf, Sox2, Hdac2 and Foxa1. Ehf, a transcriptional repressor involved in asthma 
susceptibility in humans was also enriched in Krt5+ pods (Silverman et al., 2002). 
Interestingly, Sox2 and Krt6a which were up-regulated in the colonies obtained 
from lungs post infection (Fig. 18, 19) were also up-regulated in the Krt5+ pods 
compared to the Krt5- interstitial regions. Careful analyses of Krt6a expression 
levels in the four populations of cells dissected revealed maximum up-regulation 
in the Krt5+ interstitial regions (Fig. 28A). At 15 dpi, Krt6a + cells preferentially 
localized in the interstitial regions, unlike Krt5,which stained the basal cells in 
bronchial epithelium as well as the pods in the interstitial regions (Fig. 28B).  
 
After gene level analysis, we studied the pathways enriched in the Krt5+ 
interstitial regions. The most significant pathways included those related to cell 
cycle, developmental processes, cytokinesis and cellular component 
morphogenesis, indicative of a region actively proliferating in the process of 
tissue regeneration (Fig. 27C). Moreover, pathways related to response to toxin 
and oxygen and reactive oxygen species metabolic processes were also enriched  
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in the Krt5+ interstitial regions. 
 
5.3 CONCLUSIONS AND DISCUSSION 
The aim of the experiments described in this chapter was to understand the novel 
Krt5+ population of cells in the interstitial region, also called Krt5+ pods. We 
successfully performed LCM for desired population of cells from frozen tissues 
and collected sufficient RNA for gene expression analysis. We showed that the 
biological triplicates from three mice were comparable, thus giving us a high level 
of confidence about the data obtained. The molecular analysis revealed that while 
Krt5+ and Krt5- bronchial epithelium were very similar in gene expression 
pattern, the Krt5+ pods were closer to the Krt5- interstitial regions. Thus we 
showed that Krt5+ pods are not similar to Krt5+ bronchial epithelium in whole 
genome expression analysis. In addition, we also illustrated an up-regulation of 
alveolar related genes and down-regulation of bronchial epithelium related genes 
in the Krt5+ pods. These data are very important because they exclude the 
possibility that Krt5+ pods in interstitial region lead to abnormal bronchiolization.  
 
The up-regulation of alveolar type I cell marker Pdpn, along with other alveolar 
cell type markers of endothelial cells and macrophages, as well as markers 
important for alveolar construction during development, suggested a regeneration 
process of the damaged regions by Krt5+ pods to form alveolar epithelium. 





Figure 28 : Krt6a expression in lungs during repair post infection 
A. Signal intensity of Krt6a expression across four dissected populations 12 dpi. 
Error bar represents standard deviation of the mean. B. Krt5 (green, left panel) 
and Krt6a staining (green, right panel) on consecutive sections 15 dpi in 










for tissue development further supporting the BrdU studies as well as the 
clonogenic assays in vitro. Interestingly, an enrichment of oxygen metabolism 
process was also observed in regions of Krt5+ pods further suggesting a probable 
alveolar fate of these cells. Up-regulation of markers like Krt6a, Krt14 and Sox2 
in Krt5+ pods provided us with a strong link between the Krt5+ pods observed in 
vivo and the increase in clonogenic cells obtained in vitro which are also high in 
Krt6a, Sox2, Krt14, and also had pathways related to tissue development and 
wound healing up-regulated. Further, the preferential expression Krt6a in the 
Krt5+ pods could be utilized for future studies targeting Krt5+ pods.  
 
All the above data at 12 dpi indicate that Krt5+ pods may participate in alveolar 
regeneration. Thus we analyze later time points in the coming chapters to confirm 








CHAPTER 6: ANALYSES OF DIFFERENTIATION POTENTIAL OF 
Krt5+ PODS IN VIVO 
 
6.1 INTRODUCTION 
We have established that Krt5+ pods appear in the damaged interstitial regions 
during repair post H1N1 influenza infection. We also demonstrated that they are 
clonogenic and have multipotent differentiation potential in vitro. One of the key 
features of UIP in humans is major alveolar injury due to the chronic 
inflammation. This results in deranged tissue renewal with abnormal parenchymal 
remodeling including exaggerated bronchiolar proliferation (Chilosi et al., 2002). 
Gene expression analysis of the Krt5+ pods isolated by LCM at 12 dpi suggested 
that the p63+ Krt5+ pods were not only involved in a mere bronchiolization 
process, but a possible regeneration process of the alveolar epithelium.  
 
In the alveoli, the cuboidal type II cells have the capacity to self renew as well as 
differentiate into flat type I cells and are considered as the progenitor population 
of the alveolar epithelium (Brody and Williams, 1992; Mason and Williams, 
1977). This model was established in the 1970s using primary culture systems as 
well as in vivo thymidine incorporation studies post lung injury models like NO2 
exposure and bleomycin treatment (Adamson and Bowden, 1974, 1979; Evans et 
al., 1973, 1975). More recently, Liu and colleagues (Liu et al., 2011), reported 
that alveolar type II cells mediated alveolar repair post bacterial infection. Besides 
alveolar type II cells, BASCs at the BADJ (Kim et al., 2005), as well as a unique 
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population of cells at the duct junction identified by laminin receptor 64 have 
been proposed to have alveolar differentiation potential (Chapman et al., 2011).  
 
In this chapter, we explore the possibility of Krt5+ pods contributing to the 
regeneration process of the lower airways using known and novel alveolar 
markers as well as powerful gene expression and pathway analysis.  
  
6.2 RESULTS 
6.2.1 Morphological appearance of Krt5+ pods across time 
Mice were infected with a sub-lethal dose of the H1N1 influenza virus to harvest 
lungs at later time points such as 21 dpi. At 21 dpi, lungs appeared relatively 
normal compared to the massively damaged lungs at 11 dpi, though few areas of 
dense nuclei and damaged regions still remained (Fig.5B). Fig. 29A depicts a low 
magnification, stitched representative image of lungs 21 dpi. Though most of the 
regions in the lungs look normal, several areas of Krt5+ pods surrounding bronchi 
or bronchioles in the damaged areas were still observed. Krt5 staining and 
histology of lungs at higher magnification revealed Krt5 + pods were absent in 
normal regions of the lungs (uninfected or repaired), and were also not detected in 
extremely damaged regions characterized by dense nuclei (Fig. 29B). Krt5+ pods 
were only observed in the intermediately dense regions (as observed by H&E).  
 




Figure 29 : Krt5+ pods at 21 dpi 
A. Low magnification image of Krt5 staining on mouse lung section 21 dpi. Scale 
bar represents 200µm. B. H&E and Krt5 staining on consecutive sections 21 dpi. 
Undamaged (or repaired) regions, damaged regions and Krt5+ pods in damaged 






with time. At 21 dpi the size of the Krt5+ pods was not homogeneous and 
included small tight clusters as seen at 11 dpi and also bigger hollow clusters. We 
quantified the size of the pods across time by classifying them as small tight pods 
with few cells, medium sized pods which start to hollow out and large pods which 
are single layered and have hollow lumen (Fig. 30A). The Krt5+ pods on lung 
sections from 11 dpi, 15 dpi and 21 dpi were quantified based on this size 
classification (Fig. 30B). At 11 dpi, most of the pods were small and tightly 
packed (84.5%) and only about 14.5% of pods were of medium size. The 
percentage of medium sized pods increased with time and by 15 dpi, 44% of the 
Krt5+ pods were medium sized while about 15% of the pods were larger and 
hollow. With time, by 21 dpi although the small and medium sized pods remained 
(15% and 29% respectively), majority of the pods were large and hollow in 
appearance resembling alveoli structures (56%). While still speculative, together 
these data could be interpreted as a regeneration process of the moderately dense 
area by the Krt5+ pods to form de novo alveoli.  
 
6.2.2 Krt5+ pods co-staining with lung epithelial markers 
After understanding the progressive morphology of the Krt5+ pods, to determine 
the nature of differentiation of these pods, they were co-stained with markers for 
differentiated epithelial cell types of the airways such as Clara cells, alveolar type 
I and II cells. Co-staining of Krt5+ pods with Clara cell marker CC10 at 11, 15 
and 21 dpi revealed no significant co-staining with CC10 (Fig. 31). As expected, 




Figure 30 : Kinetics of Krt5+ pods post H1N1 infection 
A. Representative images of small, medium and large Krt5+ pods observed at 21 
dpi. Scale bar represents 20µm. B. Quantification of small (blue), medium (red), 
and large (yellow) Krt5+ pods observed at 11, 15 and 21 dpi. Number of clusters 









11 dpi none of the Krt5+ pods co-stained with CC10. However, at 15 dpi some of 
the cells towards the hollow lumen in the larger multilayered Krt5+ pods were 
positive for CC10, suggesting that a subset of the Krt5+ pods could be 
contributing to de-novo bronchioles. Interestingly, by 21 dpi when majority of the 
Krt5+ pods are single layered, hollow structures, CC10 was not detected on any 
live cells in the Krt5+ pods. The hollow lumen containing debris of cells resulted 
in non-specific signal of CC10 while only the bronchial and bronchiolar 
epithelium retained clear cytoplasmic signal. Thus we concluded that few large 
Krt5+ pods could be contributing to bronchioles during repair, but all the hollow 
lumen Krt5+ pods observed at 21 dpi do not contain CC10+ Clara cells.  
 
The next step was to determine if p63+ Krt5+ cells contribute to alveolar type I 
cells. At 15 dpi, many p63+ Krt5+ cells were observed in the interstitial regions. 
We co-stained these p63+ cells at 15 dpi with alveolar type I cell marker PDPN. 
PDPN was detected in alveolar type I cells in normal lung which constitute about 
95% of the alveolar epithelium (Fig. 32A). However, at 15 dpi in damaged 
regions there was a loss of alveolar type I cells as observed by loss of PDPN 
expression. Interestingly, in interstitial regions where p63+ clusters were observed, 
PDPN was also expressed. 34% of stained cells were double positive for PDPN 
and p63, while 63% of the stained cells were PDPN single positive (Fig. 32B). 
These data suggested that p63+ cells could contribute to PDPN + type I cells in 




Figure 31 : Krt5 and CC10 across time-points post infection 
Krt5 (green) and Clara cell staining with CC10 (red) at 11, 15 and 21 dpi. White 
dotted line separates bronchiolar epithelium (Br) and alveolar epithelium. Scale 










One of the biggest setbacks in the field has been the shortage of specific alveolar 
markers. In efforts to identify novel cell specific markers, two novel hybrodomas 
1H8 and 11B6 were developed in the Xian-McKeon lab. These two hybridomas 
react specifically to alveolar type I cells (Fig. 32C, D). Krt5+ pods were co-
stained with the two hybridomas at 21 dpi when many hollow Krt5+ pods were 
observed (Fig. 32C, D). Both the hybridomas co-stained with cells in the large 
hollow Krt5+ pods but not with the small tightly clustered pods. Quantification of 
Krt5+ 11B6+ cells across time also revealed an increasing trend of double 
positive cells with maximum overlap of the cells observed at 21 dpi (Fig. 32E) 
when majority of the Krt5+ pods were big and hollow (Fig. 30B). These data 
suggested that Krt5+ pods in interstitial areas contribute to the regeneration of the 
alveolar type I cells because of the morphological phenotype as well as the 
correlation in alveolar marker staining. 
 
Next, we investigated the possibility of Krt5+ pods differentiating into alveolar 
type II cells that contribute to about 5% of the alveolar epithelium. Infected lung 
sections at 21 dpi were co-stained for Krt5 and alveolar type II cell marker SPC. 
As observed in the low magnification images in Fig. 33A, Krt5 stained the basal 
cells in the bronchial epithelium and the pods around the bronchus. When co-
stained with SPC it was observed that Krt5 and SPC regions were independent of 
each other and did not overlap. High magnification images, (Fig. 33A lower 
panel) clearly revealed a separation between Krt5+ pods and SPC+ cells with no 




Figure 32 : Krt5+ pods with alveolar type I cells markers during repair post 
H1N1 infection 
A. p63 (green) and PDPN (red) staining on mouse lung sections 15 dpi. p63 and 
PDPN staining in normal regions of lungs (left panel), damaged regions of the 
lung (middle panel) and regions of p63+ Krt5+ cells (Right panel) at 15dpi. Scale 
bar represents 50µm. B. Quantification of p63 and PDPN staining in mouse lungs 
15 dpi. 3% of the stained cells are p63 single positive (p63 sp, blue), 34% stained 
cells are p63 and PDPN double positive (p63 PDPN dp, red) and 63% of stained 
cells are PDPN single positive (PDPN sp, green). Sections from three mice at 15 
dpi were used for the quantification. C. Left panel shows 1H8 hybridoma (red) in 
bronchial and alveolar regions of normal lung. Second third and fourth panel 
shows staining of 1H8 hybridoma (red), Krt5 (green) and merged image of 1H8 
and Krt5 staining respectively on mouse lung sections 21 dpi. Scale bar represents 
50µm. D. Left panel shows 11B6 hybridoma (green) staining with Clara cell 
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marker CC10 (red) in bronchial and alveolar regions of normal lung. Second third 
and fourth panel shows staining of 11B6 hybridoma (green), Krt5 (red) and 
merged image of 11B6 and Krt5 staining respectively on mouse lung sections 21 
dpi. Scale bar represents 50µm. E. Trend of number of Krt5+11B6+ cells/mm2 of 
Krt5+ cell area at 11, 15 and 21 dpi. Error bar represents standard deviation from 
the mean. Sections from four mice/ time point were used for the quantification. 
 
mice used for infection for time points until 50 dpi (data not shown). In summary, 
we saw that Krt5 and SPC + cells did not overlap in most of the lungs, favoring 
the hypothesis that they are two independent populations. Whether the scattered 
Krt5+ cells in the large pods eventually give rise to alveolar type II cells is 
debatable and will require more efficient tracing systems to confirm.  
 
6.2.3 Gene expression profiling of Krt5+ pods 25 dpi 
After examining the morphological and phenotypic properties of Krt5+ pods we 
went on to understand the gene expression profile of different population of cells, 
25 dpi. Our studies had clearly shown that the Krt5+ pods after 21 dpi were very 
different in their morphology as well as differentiation status compared to the 
immature pods at 12 dpi. Hence we decided to isolate four populations of cells 
from mouse lung sections 25 dpi (Fig. 34), to further confirm the fate of the Krt5+ 
pods. Krt5+ pods (region 2) and normal alveoli regions marked by normal SPC 
staining pattern (region 4) were marked out for the LCM. Additionally, SPC+ 
clusters observed in damaged areas (region 1) of the lung were also intriguing and 
could be of interest, given the literature which supports the model of SPC+ cells 




Figure 33 : Krt5+ pods with alveolar type II cell marker during repair post 
H1N1 infection 
A. Low magnification image of Krt5 (green) and SPC (red) staining on mouse 
lung sections 21 dpi. Scale bar represents 50µm. Lower panel represents high 
magnification image of Krt5 (green) and SPC (red) staining on mouse lung 















Hence, we isolated the SPC+ clusters and as a control, also marked out Krt5- 
SPC- damaged regions post infection (region 3). To confirm the nature of all the 
populations of cells we co-stained the SPC or Krt5 regions with alveolar type 1 
hybridomas namely, 1H8 and 11B6 (Fig. 35A, B). Region 1 with SPC+ clusters in 
damaged lungs were not positive for normal alveoli markers such as 1H8 or 11B6, 
confirming that those regions were not normal alveoli regions but SPC+ damaged 
alveoli regions. Region 2, consisting of Krt5+ pods had some co-staining with 
alveolar markers mirroring results at 21 dpi (Fig. 32C, D). Region 3, which was 
SPC- and Krt5- was also negative for alveolar markers 1H8 or 11B6 thus 
validating the damaged alveoli status. Lastly, region 4, which was characterized 
as SPC+ normal alveoli region were also positive for alveolar hybridomas 
confirming they were normal alveoli regions. 
 
After the LCM of the four populations of cells, from three mouse lungs, the RNA 
extracted was amplified and hybridized on gene chip arrays as described earlier 
(Chapter 2, 5). Preliminary molecular analysis revealed that the biological 
triplicates for all four samples were consistent with each other (Fig. 36A). Also, 
from the PCA map it was observed that the normal alveoli samples were far away 
from the damaged alveoli region, based on whole transcriptome analysis as 
expected. Interestingly, the Krt5+ pods were closer to normal alveoli region in 
whole genome expression pattern compared to the damaged alveoli regions. 





Figure 34 : Krt5 and SPC in mouse lungs 25 dpi 
A. Representative image of SPC (red) and Kr5 (green) staining on mouse lung 
frozen sections 25 dpi. Scale bar represents 200µm. Regions marked are SPC+ 
damaged alveoli (1), Krt5+ pods (2), damaged alveoli (3) and normal alveoli (4). 
Scale bar represents 200µm. Inset on right shows higher magnification of four 






compared to the normal alveoli in whole genome expression. Next, we performed 
unsupervised clustering analysis on significantly differentially expressed genes 
(Fig. 36B). The normal alveoli and Krt5+ pods clustered together, while the 
damaged alveoli and SPC+ DA formed a separate cluster. Majority of the genes 
were commonly expressed in the damaged alveolar regions as well as the SPC+ 
DA regions and were not expressed in normal alveoli as well as Krt5+ pods (809 
genes, Cluster D). Similarly, several genes were commonly expressed in normal 
alveoli and Krt5+ pods (281 genes, Cluster B) compared to the damaged regions. 
There were also a large number of genes that were expressed only in normal 
alveoli (600 genes, Cluster C) or only specific to Krt5+ pods (515 genes, Cluster 
A).  
 
We scrutinized the Cluster B set of genes that consisted of genes commonly high 
in Krt5+ pods and normal alveoli (Fig. 36C). Alveolar type I markers such as 
Pdpn and Aqp5 were detected to be commonly high in normal alveolar regions 
and Krt5+ pods. Atp1b1, a Na-K-ATPase localized on alveolar type I cells (Borok 
et al., 2002) as well as Scnn1g, an amiloride-sensitive epithelial sodium channel 
which has been reported to be important for alveolar fluid clearance were up-
regulated in Krt5+ pods (Hummler and Planès, 2010; Machado-Aranda et al., 
2005). Other interesting genes include Caveolin-1 (Cav1), a major scaffolding 
protein constituent of caveolae (Ryter and Choi, 2008). In adult lung, Cav1 is 




Figure 35 : Alveolar type I cell marker with Krt5 and SPC at 25 dpi 
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A. Left top panel represents region 1: SPC+ damaged alveoli stained with SPC 
(red) and 1H8 (green). Right top panel represents region 2: Krt5+ pods stained 
with Krt5 (red) and 1H8 (green). Left bottom panel represents region 3: SPC- 
Krt5-damaged alveoli (DA) stained with SPC red and 1H8 green. Right bottom 
panel represents region 4: normal lung with SPC (red) and 1H8 (green). All 
sections are from mouse lungs at 25 dpi. Scale bar represents 20µm. B. Left top 
panel represents region 1: SPC+ damaged alveoli stained with SPC (red) and 
11B6 (green). Right top panel represents region 2: Krt5+ pods stained with Krt5 
(red) and 11B6 (green). Left bottom panel represents region3: SPC- Krt5- 
damaged alveoli (DA) stained with SPC red and 11B6 green. Right bottom panel 
represents region 4: normal lung SPC (red) and 11B6 (green). All sections are 
from mouse lungs at 25 dpi. Scale bar represents 20µm. 
 
Laminin 2 (Lamc2), which is prominently expressed in the basement membrane 
of alveolar walls and airways of developing and adult lung (Nguyen et al., 2006) 
was enriched in normal and Krt5+ pods. Cul7, (Huber et al., 2011; Petroski and 
Deshaies, 2005) and Pdgfra, important genes involved in normal alveolar 
development were also prominently observed in the Krt5+ pods and normal 
alveoli.    
 
Next, we performed detailed pathway analysis of the four clusters of genes using 
the PANTHER pathway database discussed earlier (Fig. 37). Gene ontology 
analysis of Cluster B representing genes commonly elevated in normal alveoli and 
Krt5+ pods revealed several interesting pathways including, 5-Hydroxytryptamine 
degradation and Phenylethylamine degradation. Degradation of amines such as 5-
hydroxytryptamine (5-HT), or serotonin, a vasoconstrictor and phenylethylamine 
by monoamine oxidase (MAO) in the lungs (Bakhle and Youdim, 1979; Gillis 




Figure 36 : Gene expression analysis of Krt5+ pods at 25 dpi 
PCA analysis of different populations of cells dissected out at 25 dpi. The four 
regions dissected out are SPC+ normal alveoli region (region 4, red), Krt5+ pods 
(region 2, purple), SPC+ damaged alveoli (region 1, blue), Damaged alveolar 
regions (region 3, green). B. Unsupervised clustering of the four dissected regions 
at 25 dpi namely SPC+ damaged alveoli, damaged alveoli, Krt5+ pods and 
normal alveoli with p<0.05 including 2205 genes. Cluster of genes marked out in 
the heatmap. Cluster A consists of 515 genes specifically up-regulated in Krt5+ 
pods. Cluster B consists of 281 genes commonly expressed in Krt5+ pods and 
normal alveoli, Cluster C consists of 600 genes specifically expressed in normal 
alveoli while Cluster D consists of 809 genes commonly expressed in SPC+ 
damaged alveoli as well as damaged alveoli. C. Expression pattern of alveolar 
region related genes in four dissected regions 25 dpi namely Normal alveoli, 








endothelium signaling and angiogenesis pathways which are essential for 
functional alveoli units of gas exchange (Khimji and Rockey, 2010) were also 
enriched in Cluster B genes (Fig. 37B). Over-representation of genes involved in 
Wnt, Hedgehog, and nicotinic acetylcholine receptor signaling were also observed 
in the Cluster B genes (Table 3).  
 
The pathways significantly enriched in Cluster A genes, which was specific to 
Krt5+ pods included pathways such as axonal guidance by netrins. While netrins 
are known to regulate axonal guidance in multiple systems, they have also been 
reported to have crucial effects on epithelial and endothelial cells during lung 
development (Liu et al., 2004). Besides these, several metabolic pathways such as 
fructose galactose metabolism and glutamine to glutamate conversion were also 
enriched in Krt5+ pods. Reports state that since lungs have high flow of blood 
owing to pulmonary circulation, they express the glutamine synthetase enzyme 
for glutamine metabolism to catalyze de novo glutamine biosynthesis (Karinch et 
al., 2001). Additionally, it has also been speculated that in severe pulmonary 
dysfunction, due to metabolic failure, the damaged lungs are unable to release 
sufficient amounts of glutamine (Souba et al., 1990). Glutamine is also a key 
source of energy in the developing lung (Fox et al., 1996). Insulin/IGF pathway, 
and the PI3 kinase pathway (Thomas and Owen, 2008), also enriched in 
Krt5+pods have been implicated to play an important role in lung diseases and are 




Figure 37 : Pathway analysis of clusters 25 dpi 
A. Gene ontology analysis of genes in Cluster A with respective p-values. B. 
Gene ontology analysis of genes in Cluster B with respective p-values. C. Gene 
ontology analysis of genes in Cluster C with respective p-values. D. Gene 
ontology analysis of genes in Cluster D with respective p-values. p<0.05. Black 
bar represents genes from the marked clusters while white bars represent genes 





Together, these data suggested that the Krt5+ pods, in association with elements 
involved in capillary formation were attempting to reconstruct a functional 
alveolar network.   
 
Cluster C, which consisted of genes enriched in normal alveoli included Integrin 
signaling, angiogenesis, Nicotinic acethylcholine receptor signaling and Axon 
guidance by semaphorins pathways (Fig. 37C). Cluster D, which represented 
genes from damaged alveoli had mostly immune response and proliferation 
pathways up-regulated including T and B cell activation, Inflammation by 
cytokines, TLR signaling and DNA replication.  
 
6.3 CONCLUSIONS AND DISCUSSION 
In this chapter, we demonstrated that Krt5+ pods, which were observed in the 
moderately damaged regions, individually expanded in size with time, and by 21 
dpi formed large hollow structures reminiscence of alveoli. Some Krt5+ pods may 
have developed into de novo bronchioles as suggested by CC10 staining at 15 dpi 
but by 21 dpi the hollow lumen Krt5+ pods developed into alveolar type I cells. 
The general problem in the field has been the lack of specific markers for all 
differentiated cell types in the lung. Amongst the hybridomas developed in the 
Xian-McKeon lab, the 1H8 and 11B6 hybridomas reacted specifically to alveolar 
type I cells. Post infection, the damaged alveolar region was detected by the loss 
of the hybridoma staining. However, in regions with Krt5 signal in large hollow 
pods, co-staining of alveolar markers was observed again. While the Krt5+ pods 
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Pathways enriched in cluster A (515) 
genes by GO with p<0.02    
Cluster A    
Pathways % of cluster A 
% of whole 
genome P value 
Fructose galactose metabolism 0.66 0.05 0.00203 
Glutamine glutamate conversion 0.44 0.02 0.0036 
PI3 kinase pathway 1.31 0.42 0.0138 
Axon guidance mediated by netrin 0.66 0.11 0.0149 
Insulin/IGF pathway-protein kinase B 
signaling cascade 1.09 0.32 0.0162 
Flavin biosynthesis 0.22 0.00 0.0173 
    
    
Pathways enriched in cluster B (281) 
genes by GO with p<0.02    
Cluster B    
Pathways % of cluster B 
% of whole 
genome P value 
5-Hydroxytryptamine degredation 1.91 0.09 4.29E-06 
Phenylethylamine degradation 1.53 0.05 0.000014 
Alzheimer disease-presenilin 
pathway 3.05 0.47 4.31E-05 
Endothelin signaling pathway 2.29 0.34 0.000312 
Angiogenesis 3.05 0.74 0.000827 
Cadherin signaling pathway 2.67 0.64 0.00163 
Hedgehog signaling pathway 1.15 0.10 0.00214 
Wnt signaling pathway 3.44 1.33 0.00908 
GABA-B_receptor_II_signaling 1.15 0.16 0.00957 
EGF receptor signaling pathway 1.91 0.53 0.0132 
Beta2 adrenergic receptor signaling 
pathway 1.15 0.19 0.0136 
Beta1 adrenergic receptor signaling 
pathway 1.15 0.19 0.0136 
Heterotrimeric G-protein signaling 
pathway-Gq alpha and Go alpha 
mediated pathway 1.91 0.53 0.0136 
TCA cycle 0.76 0.07 0.0144 
Nicotinic acetylcholine receptor 
signaling pathway 1.53 0.37 0.0176 
Metabotropic glutamate receptor 
group II pathway 1.15 0.21 0.0184 
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Pathways enriched in cluster C (600) 
genes by GO with p<0.02    
Cluster C    
Pathways % of cluster C 
% of whole 
genome P value 
Integrin signalling pathway 4.08 0.71 4.06E-11 
Angiogenesis 3.72 0.74 2.92E-09 
Nicotinic acetylcholine receptor 
signaling pathway 2.13 0.37 2.17E-06 
Alzheimer disease-presenilin 
pathway 2.13 0.47 2.22E-05 
Axon guidance mediated by 
semaphorins 1.24 0.17 5.82E-05 
VEGF signaling pathway 1.24 0.29 0.00149 
Inflammation mediated by 
chemokine and cytokine signaling 
pathway 2.66 1.14 0.00247 
PDGF signaling pathway 1.60 0.62 0.00946 
Axon guidance mediated by 
Slit/Robo 0.53 0.08 0.011 
B cell activation 1.06 0.33 0.0123 
    
    
Pathways enriched in cluster D (809) 
genes by GO with p<0.02    
Cluster D    
Pathways % of cluster D 
% of whole 
genome P value 
Inflammation mediated by 
chemokine and cytokine signaling 
pathway 4.40 1.14 2.11E-10 
T cell activation 3.02 0.54 2.2E-10 
B cell activation 2.34 0.33 8.35E-10 
Toll receptor signaling pathway 1.37 0.24 1.69E-05 
DNA replication 0.69 0.10 0.000754 
PDGF signaling pathway 1.79 0.62 0.000775 
Integrin signalling pathway 1.79 0.71 0.00246 
JAK/STAT signaling pathway 0.55 0.08 0.00255 
p53 pathway feedback loops 2 0.82 0.19 0.00336 
EGF receptor signaling pathway 1.37 0.53 0.00604 
Heterotrimeric G-protein signaling 
pathway-Gq alpha and Go alpha 
mediated pathway 1.37 0.53 0.00633 
Apoptosis signaling pathway 1.37 0.54 0.00696 
Axon guidance mediated by netrin 0.55 0.11 0.00927 
FGF signaling pathway 1.24 0.48 0.00929 
Interferon-gamma signaling pathway 0.55 0.11 0.0104 
Thyrotropin-releasing hormone 




Table 3 : Pathway analysis of clusters 25 dpi 
List of pathways enriched in cluster A, B, C and D with p<0.02. 
 
co-stained well with alveolar type I cell markers they were most of the times not 
co-expressed with alveolar type II marker SPC. These results were against the 
norm in the field which believes that SPC+ cells give rise to alveolar type I cells. 
While this course of repair was not completely excluded in the regeneration 
process, the Krt5+ pods seemed to give rise to alveolar type I cells without 
differentiating into alveolar type II cells first. Further, these results did not 
exclude the possibility that the scattered Krt5+ cells in the large Krt5+ pods could 
eventually convert to SPC+ alveolar type II cells. The transitional phase when 
Krt5 and SPC were co-expressed in the same cells might be very short and thus it 
was a very rare phenomenon to observe. Whether or not the Krt5+ cells can 
eventually differentiate into alveolar type II cells requires further investigation 
using more sophisticated model systems like lineage tracing or carefully 
monitored in vivo differentiation assays.  
 
Gene expression profiling of four different regions of the lungs at 25 dpi provided 
the most intriguing evidence favoring a role for Krt5+ pods in alveolar 
regeneration. The 25 dpi LCM data further validated the notion obtained from the 
LCM data of Krt5+ pods at 12 dpi, that they were involved in alveolar 
regeneration. While some markers such as Krt6a involved in wound healing and 
Pdgfra involved in normal lung development were commonly high in Krt5+ pods 
across time, the molecular analysis at a later time point opened up a whole new 
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avenue to explore. We observed that Krt5+ pods and normal alveoli shared 
common cluster of genes (Cluster B), which were enriched in several biochemical 
pathways typical of normal alveolar function. Moreover, a potential role of 
nicotinamide acetylcholine receptor signaling common to normal alveoli and 
Krt5+ pods also suggested development of neuronal signaling in the lungs 
(Coughlin, 1975; Knox et al., 2010; Proctor and Carpenter, 2007; Wongtrakool et 
al., 2007) . Krt5+ pods were also enriched in signaling pathways involving PI-
3Kinase and insulin as well as metabolic pathways involving glutamine-glutamate 
conversion. Although speculative, these pathways could be fulfilling the high 
metabolic demand of the Krt5+ pods actively involved in the regeneration process, 
the same way these pathways are actively involved in lung development (Fox et 
al., 1996). 
 
During lung development, the alveolar budding and development of vascular 
capillaries occur in parallel (Cardoso, 2001; Metzger et al., 2008; White et al., 
2007).  The lungs are the functional gas exchange units of the respiratory system 
and the alveolar capillary interface is pivotal for transfer of oxygen to the blood 
for circulation (Huh et al., 2010; Petersen et al., 2010; Vaporciyan et al., 1993). 
Recently, Ding and colleagues (Ding et al., 2011) demonstrated that during 
regeneration, pulmonary endothelial cells sprout to initiate angiogenesis and 
fulfill the gas exchange requirements of the lungs. They are also capable of 
facilitating alveolarization in the lungs via angiocrine signals involving MMP14 
or activation of VEGFR2 and FGFR1. The enrichment of pathways related to 
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angiogenesis and endothelium signaling in the Krt5+ pods supported this notion 
that capillaries are a functional unit of the alveoli and the pulmonary endothelial 
cells may also be involved in guiding de-novo alveolar regeneration. 
 
Interestingly, SPC+ clusters in damaged alveoli were closer to the damaged 
alveoli compared to the normal alveoli in terms of staining with alveolar 
hybridomas as well as gene expression profiles. They shared similar gene 
expression patterns with pathways enriched in TLR signaling, and immune cell 
activation including T and B cells, while alveolar region specific markers like 
PDPN and Aqp5 were down-regulated in these regions. However we cannot 
exclude the possibility that the SPC+ clusters in damaged alveoli could also be 
contributing to a delayed regeneration process in the lungs. 
 
On the broadest level, we concluded that regions with Krt5 pods expressed genes 
similar to apparently normal or repaired lung, and were very different from 
regions marked by severe damage. The data suggested that a dynamic 
regeneration process with a host of interesting pathways could be involved in the 
recovery of lungs from ARDS. The study of these pathways will require extensive 
empirical validation to determine their clinical significance. 
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CHAPTER 7: GENETIC TRACING OF Krt5+ PODS DURING REPAIR 
 
7.1 INTRODUCTION 
We have identified Krt5+ pods during the repair process post H1N1 infection that 
contribute to the regeneration of the alveolar epithelium. The next question we 
addressed was the origin of these p63+ Krt5+ pods. p63+ Krt5+ cells in the 
normal lungs are detected only in the basal layer of the bronchial epithelium. 
During regeneration however, these cells were observed in bronchiolar epithelium 
as well as in the interstitial damaged regions in the distal airways. To determine 
the origin of these cells, we adopted a lineage tracing system that genetically tags 
cells. The labeled cells and their daughter cells can then be traced at a later time 
point even if the cells shut down the expression of the specific promoter, or have 
differentiated into other cell types.  
 
The Cre-loxp recombination is a site-specific recombination system in which Cre, 
a 38-kDa protein, is both necessary and sufficient to catalyze recombination 
between two loxp sites, each of which is 34 bp in length (Abremski et al., 1983; 
Hoess and Abremski, 1985; Sternberg et al., 1981). This system was initially used 
for activating gene expression in yeast and mammalian cell lines (Sauer, 1987; 
Sauer and Henderson, 1988). Subsequently, Orban and colleagues (Orban et al., 
1992) showed that Cre-lox recombination could be used to delete loxP-flanked 
chromosomal DNA sequences at high efficiency in selected cell types of 
142 
 
transgenic animals, suggesting this approach as a means to define gene function in 
specific cell types, indelibly mark progenitors in cell fate determination studies, 
induce specific chromosomal rearrangements for biological and disease modeling, 
and determine the roles of early genetic lesions in disease (and phenotype) 
maintenance. To control the temporal activity of the Cre excision reaction, forms 
of Cre which take advantage of various ligand-binding domains have been 
developed. One successful strategy for inducing temporally specific Cre activity 
involves fusing the enzyme with a mutated ligand-binding domain of the human 
estrogen receptor (ERt), (Littlewood et al., 1995). This system was fused together 
with the promoter driven Cre system to generate promoter driven Cre-ERt mice.  
 
In this chapter, we demonstrate that the p63+Krt5+ pods observed during repair 
are also positive for Krt14 and hence the Krt14 promoter driven CreERt mouse 
(Vasioukhin et al., 1999) was used for genetic tracing of these cells. The Krt14 
promoter specific CreERt mouse, was crossed with a reporter mouse, which could 
be induced to have constitutive expression of  galactosidase because of its 
location in the constitutively expressed Rosa26 locus (Mao et al., 1999). In these 
mice ERt binds endogenous estrogens, which allows Cre-ERt to remain 
cytoplasmic in animals untreated with tamoxifen. However upon tamoxifen (an 
estrogen receptor antagonist) injection, the Cre-ERt construct is able to penetrate 
the nucleus and induce recombination at loxp-flanked sites. This leads to the 
removal of the stop codon flanked by the loxp sites thus resulting in constitutive 
expression of  galactosidase under the Rosa26 locus.  
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Using this genetic tracing system we trace the p63+ Krt5+ Krt14+ cells during 
repair in the lungs to determine the origin of these pods in alveolar regions. 
 
7.2 RESULTS 
7.2.1 Kinetics of Krt5+ Krt14+ pods post infection 
p63+ Krt5+ pods are observed in interstitial regions from 11 dpi. Interestingly, in 
damaged regions where bronchioles were not Krt5+ there were no Krt5+ pods 
surrounding them. Krt5+ pods were associated with Krt5+ bronchioles (Fig. 38A) 
about 95% of the times. These data suggested that Krt5+ pods in the interstitial 
areas could be the result of the migration of Krt5+ cells from the basal layer of the 
bronchial epithelium. 
 
Interesting, Krt5+ pods also expressed other Keratin markers like Krt14 (Fig.27B, 
Fig.38 B), 15 dpi. We analyzed the kinetics of Krt14 staining in mouse lungs post 
infection. Unlike Krt5, which stained a few basal cells in the bronchial epithelium 
of normal lungs, Krt14 was nearly absent by staining in normal lungs (Fig. 39A). 
However, by 7 dpi, Krt14+ cells were observed in the bronchial epithelium, which 
increased in number at 9 dpi. Until 9 dpi, the Krt14+ cells were only restricted to 
the bronchial epithelium and by 11 dpi, small pods of Krt14+ cells were observed 
in the damaged alveolar regions which progressed in size with time and by 21 dpi 
scattered Krt14+ cells in large alveolar like networks were detected. We 




Figure 38 : Association of Krt5+ pods with bronchi 
A. Krt5 IHC on mouse lung section 12 dpi. Red star marks bronchioles with 
Krt5+ cells. Green star marks bronchioles without Krt5+ cells. Scale bar 
represents 100µm. Right panel shows high magnification of Krt5+ bronchiole 
with Krt5+ pods around it and Krt5- bronchioles without Krt5+ pods around it. 
Right bottom panel represents quantification of the % of times the regions with 
Krt5+ pods are associated with a Krt5+ bronchus. Number of regions, n=32. Error 
bar represents standard deviation from mean. B. Krt5 (red) and Krt14 (green) co-










illustrated the presence of Krt14+ cells being restricted to the bronchial 
epithelium at 7 and 9 dpi, and from 11 dpi, Krt14+ cells were also observed in 
alveolar regions. We decided to genetically trace these Krt5+ Krt14+ cells using 
the Krt14+ promoter to determine the origin and fate of the pods. 
 
7.2.2 Lineage tracing of Krt14+ cells post infection 
To trace the Krt5+ Krt14+ cells during repair post infection we crossed the Krt14 
promoter driven CreERt mouse with the loxp-flanked LacZ mice under the 
constitutive Rosa26 locus. (Fig. 40A) Off-spring from matings were genotyped 
using standard primers to check for the 110 bp CreErT2 insert, and 340 bp and 
650 bp inserts for heterozygous mice for the LacZ transgene (Fig. 40B). 
Experiments were performed on mice heterozygous for both the alleles. 
 
From the kinetics of Krt14 expression in lungs during repair (Fig. 39) we planned 
to inject tamoxifen at day 5, 6 and 7 post infection (Fig.40C). At these time points, 
the Krt14+ cells were restricted to the basal layer of the bronchial epithelium only. 
The tamoxifen injections would induce Cre recombination in Krt14+ cells, which 
were restricted to the bronchial epithelium only until 9 dpi (Fig. 39). Our 
hypothesis was that if the Krt14+ cells migrated from the bronchial epithelium to 
the interstitial region during repair the Krt14+ cells labeled by  galactosidase 
expression on tamoxifen injection would also be observed in the alveolar region at 





Figure 39 : Krt14 staining pattern over time post infection 
A Krt14 (red) staining at 0, 7, 9, 11 and 25 dpi. White dotted line separates 
bronchial (Br) and alveolar regions. Scale bar represents 20µm. B. Quantification 
of % of Krt14+ cells in bronchioles (blue) and interstitial regions (red) at 7, 9, 11 














Infected mice were injected with tamoxifen or oil 5-7 dpi and sacrificed at 25 dpi 
to harvest lungs and skin (positive control). Fig. 41A shows that while the lungs 
from oil (vector control) injected mice had no blue regions after X-gal staining, 
small blue regions were observed in lungs from tamoxifen injected mice (Fig. 
41B). Skin was used as a positive control for all experiments. Krt14 promoter is 
highly active in the basal layer of the epidermis and obtaining blue color in the 
skin provided us with confirmation about the genotype of the mouse, as well as 
confirmed the tamoxifen activity and X-gal staining procedures. We observed that 
this system is leaky in the skin, as even in oil-injected mice the skin contained 
blue cells. This could be attributed to the extremely high Krt14 promoter activity 
in the skin as well as the intrinsic leaky nature of the CreERt system. However, no 
leakage in  galactosidase expression in the lungs was observed confirming the 
blue regions observed in lungs in tamoxifen injected, infected mice were due to 
induced expression of  galactosidase due to tamoxifen inductions from 5-7 dpi.  
 
Fig. 42A shows high magnification of X-gal stained blue regions in a lobe of the 
infected lungs at 25 dpi. Sections through these regions revealed X-gal stained  
galactosidase+ blue cells in the small bronchiolar epithelium, as well as in 
interstitial areas (Fig. 42B). To confirm that the X-gal staining is observed in 
regions of Krt5+ pods we co-stained X-gal treated lungs with Krt5. Fig. 42C 
shows a low magnification image of X-gal stained cells. The stained cells were 
detected in the zone between normal (or repaired) appearing alveoli regions and 





Figure 40 : Mice used for lineage tracing of Krt5+ pods 
A. Krt14 promoter driven CreERt mice (KRT14-cre/ERt) were mated with 
Rosa26 LacZ mice (Gt(ROSA)26Sortm1Sor). B. Genotyping results of KRT14-
cre/ERt mice (left panel) and Gt(ROSA)26Sortm1Sor (right panel). Left panel 
represents the genotyping result of heterozygous Krt14CreERt mice with Cre 
insert at 104 bp and internal positive control band at 400 bp. Wild type mice only 
have the 400 bp internal positive control band while negative control (NC) has no 
amplification band. Right panel represents the genotyping result of Rosa26 Lacz 
mice from lane one to four. Homozygous insert band is at 340 bp, heterozygous 
bands at 340 and 650 bp, wild type band is at 650 bp and negative control has no 
amplification band. C. Schematic of experimental design for lineage tracing 
experiments. Mice infected with a sub-lethal dose of the H1N1 influenza virus 
were injected with 200mg/kg tamoxifen (IP) at 5,6 and 7 dpi. Mice were 






Figure 41 : Whole mount X-gal staining of tissues post infection 
A. Left panel represents X-gal stained lungs from two different (Krt14 CreERt x 
Rosa lacz) mice that were infected with sub-lethal dose of H1N1 and injected 
with oil at 5, 6 and 7 dpi. Bottom left panel represents skin from oil-injected mice, 
which were also stained with X-gal. A. Right panel represents X-gal stained lungs 
from two different (Krt14 CreERt x Rosa lacz) mice, which were infected with 
sub-lethal dose of H1N1 and injected with 200mg/kg tamoxifen at 5, 6 and 7 dpi. 
Arrow marks blue regions in the lungs post X-gal staining. Bottom left panel 









image of the X-gal stained region in the small bronchiolar epithelium as well as in 
the alveolar regions was clearly observed (Fig. 42D). Few cells in the bronchiolar 
epithelium and some blue cells in the interstitial regions still retained their Krt5 
staining. These data support our hypothesis that Krt14+ cells labeled in the 
bronchial or bronchiolar epithelium migrate out to adjacent damaged alveolar 
regions during repair. Co-staining of these small X-gal positive regions with 
alveolar makers such as 1H8 revealed faint overlap in the staining patterns (Fig. 
42E). These data, all though not conclusive, further supports an alveolar fate of 
the lineage labeled cells.  
 
7.3 CONCLUSIONS AND DISCUSSION 
In this chapter, we address the question of the origin of the Krt5+ pods during 
repair. The close association of Krt5+ pods with Krt5+ bronchi throughout 
infection, the clear absence of Krt5+ cells in normal alveolar regions, as well as 
expression of metallo-protease proteins in the Krt5+ pods lead us to our 
hypothesis that, the p63+ Krt5+ Krt14+ cells from the bronchial epithelium 
migrate out to the damaged interstitial region when needed, to participate in the 
repair of the alveolar epithelium. To confirm this hypothesis, we used genetic 
tracing systems using the Cre-loxp system under the Krt14 promoter. The 
recombination event to initiate the genetic tracing was induced by tamoxifen 
injections from 5-7 dpi. The Krt14+ cells in bronchial and bronchiolar epithelium 
were labeled, and these cells were traced until 25 dpi. Interestingly at 25 dpi, X-





Figure 42 : Genetic tracing of Krt5+ Krt14+ pods post infection 
A. High magnification image of X-gal stained lung 25 dpi. B. X-gal stained 
mouse lung section 25 dpi counter-stained with nuclear fast red. Scale bar 
represents 20µm. C. Left panel represents low magnification image of X-gal 
(blue) and Krt5 (brown) on mouse lung section 25 dpi. Right panel represents 
higher magnification image of the same area with X-gal and Krt5+ cells. Br: 
bronchiole. Arrows point to X-gal positive regions in the interstitial areas. Scale 
bar represents 20µm. D. Left panel represents staining of 1H8 and SPC on mouse 
lung sections 25 dpi. Right panel represents X-gal staining pattern on the same 
section. Scale bar represents 20µm. 
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interstitial regions. This experiment thus confirmed our hypothesis of p63+ Krt5+ 
Krt14+ cells migrating into damaged interstitial regions to enable alveolar 
regeneration (Fig. 43).  
 
While some of the lineage labeled cells still retained Krt5 expression, many of the 
blue cells in the interstitial areas were observed in zones between Krt5+ regions 
and normal/repaired alveoli regions. Staining of these cells with differentiation 
alveolar markers revealed a possible co-stain. Although these experiments 
conformed the origin of the Krt5+ pods observed during repair, the ultimate fate 
of the pods to normal alveoli still requires confirmation using more efficient 
lineage tracing systems with better promoters such as Krt5 or Krt6a. The inherent 
limitation of the Krt14 promoter driven CreERt system in the airways leads to not 
so frequent recombination events in the lung during repair. Whether this is due to 
the low promoter activity in the airways or inherent chromatin structure problems 
is unknown. This low recombination efficiency does not allow us to determine the 
ultimate fate of the large Krt5+ pods observed during repair. Ongoing 
experiments hope to address these unanswered questions pertaining to the 




Figure 43 : Model for distal airway regeneration post H1N1 infection 
p63+ Krt5+ basal cells (green) are present in the basal layer of bronchial 
epithelium in normal lungs. 7 dpi, massive damage is observed in bronchial and 
alveolar epithelium. In some bronchi and bronchioles the p63+Krt5+ basal cells 
proliferate to regenerate the damaged epithelium. By 11 dpi when the interstitial 
alveolar damage is at its peak, the p63+ Krt5+ basal cells migrate out into the 
damaged regions to form discreet pods. With time these pods differentiate into 
alveolar cell types to regenerate the alveolar epithelium. Mechanisms underlying 




























CHAPTER 8: IMPLICATIONS AND FUTURE DIRECTIONS 
 
In this study, we identify and characterize a novel population of p63+ Krt5+ cells 
in the distal airways during repair post H1N1 influenza virus induced ARDS. We 
illustrate that p63+ Krt5+ cells, normally residing in the basal layer of bronchial 
epithelium, migrate into the interstitial regions during extreme alveolar damage 
and form discreet p63+ Krt5+ pods that contribute to proposed alveolar 
reconstruction during repair. While p63+ Krt5+ cells have been designated as the 
stem cells for the upper airways, their role in the regeneration of lower airways 
was not known. Further, no robust stem cell population has been identified for the 
lower airways of the respiratory system. In our study, by using an in vivo infection 
induced ARDS model, in parallel with an in vitro pedigree system for cloning and 
molecular analysis of regio-specific human airway stem cells (work by Dr. 
Yuanyu Hu, Xian-McKeon lab) we demonstrate that p63+ Krt5+ distal airway 
stem cells contribute to alveolar regeneration (Kumar et al., 2011). 
 
A sub-lethal dose of the virus was used in our system to induce lung damage 
while also allowing a repair process. The kinetics of damage and repair in our 
study were predicted based on parameters such as bodyweight kinetics and 
histology in different mice across time. Although these experiments provided us 
with the fundamental time-line of the damage and repair process, a better system 
for precise spatial and temporal kinetics would be greatly beneficial. Probably a 
more efficient and accurate method of probing for inflammation, injury and 
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epithelial repair across time in the H1N1 infected mouse lungs could be possible 
using modern imaging technologies like Positron Emission Tomography (PET) 
imaging of small animals in combination with transgenic animals or specific 
biomarkers. Live imaging of lungs in small animals has been a challenge in the 
past but researchers now use different forms of PET imaging in lungs for several 
applications, including probing for particular cell types in inflammatory diseases, 
as well as to detect or target lung cancers (Locke et al., 2009; Nielsen et al., 2010). 
These tools could be utilized to conduct high-resolution analysis of pulmonary 
populations of cells, which would reveal a better temporal understanding of the 
entire damage and repair process in the same mouse and also uncover possible 
repair mechanisms.  
 
Further, our analyses on lung damage and repair are based on histology and 
marker expression. Our detailed study ruled out the possibility of abnormal 
bronchiolization and fibrosis, which are typical pathological conditions in airway 
diseases including pneumonia. A possible alveolar fate of the Krt5+ pods was 
concluded based on known alveolar markers in the field as well as novel 
hybridomas against alveolar cell types for mouse and rat developed in the Xian-
McKeon lab. Gene expression analysis also revealed an orchestrated alveolar 
development phase with enrichment of several genes involved in alveolar 
epithelium development along with endothelial capillary bed formation. More 
sophisticated lineage tracing systems with better promoters will confirm this 
proposed alveolarization process. 
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While these data point to an alveolar reconstruction process, the true functionality 
of alveolar region post regeneration in the lungs of these mice remains unknown. 
Several invasive and non-invasive methods of lung function assessment routinely 
used for human studies have now also been adapted to mouse models (Glaab et al., 
2007; Verhoeven et al., 2009). One of the classical methods of monitoring lung 
function involves an invasive orotracheal intubation procedure to measure 
parameters such as pulmonary resistance (RL) or dynamic compliance (Cdyn) for 
accurate and specific determination of pulmonary mechanics. Low-frequency 
forced oscillation technique (LFOT) estimates lung impedance (Z), which 
provides more detailed measurements of pulmonary mechanics. Several 
noninvasive methods for monitoring pulmonary function have also been 
developed for long-term experiments which allow continuous evaluation of 
pulmonary function of a large number of animals across time. For example, in 
humans, non-invasive pulse-oximeter readings provide an important clinical 
readout of morbidity in respiratory diseases (Sidwell et al., 1992). This technique 
involves the spectrophotometric analysis of the percent of oxygenated 
hemoglobin in the blood, a direct measure of lung function and blood oxygenation 
(Wahr et al., 1995). These different assays individually, or in combination could 
be utilized in our experiments in the future to understand the physiologic 
significance of respiratory phenotypes including damage and repair. Further, the 
functionality of regenerated alveolar epithelium can also be quantified using these 




In this work we characterized the unique epithelial population of p63+ Krt5+ pods 
in the interstitial region. All though these cells are actively proliferating in vivo 
and also have clonogenic potential in vitro, they are not linked to other stem cell 
populations such as BASCs. Further, the norm in the field has been that alveolar 
type II cells differentiate into alveolar type I cells in the lungs. In our experiments 
we speculate that Krt5+ pods differentiate into type I cells first, independent of an 
alveolar type II cell transition phase. Whether the Krt5+ pods ultimately 
differentiate into type II cells is still debatable. Further, we do not exclude the 
possibility that alveolar type II cells or even BASCs may be involved in an 
independent, delayed regenerative process. Detailed studies involving in vitro 
differentiation assays as well as multiple lineage tracing systems will be required 
to understand the contributions of these different populations of cells during 
repair.  
 
In-depth gene expression analysis of Krt5+ pods in lung regeneration provides a 
very rich and previously unavailable database of molecular factors and pathways 
participating in the damage and repair process in vivo. Efforts will have to be 
made to maximize the knowledge that we can extract from these datasets. Several 
chemokines, MMPs, transcription factors, surface receptors and pathways have 
been identified in our study. Many of these markers could be used to develop 
powerful tools for further experimentation and validation. Further, large scale in 
vitro validation experiments will be required to dissect out the underlying 
mechanisms of the migration and differentiation of Krt5+ pods. For this, the 
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mouse in vitro stem cell culture will have to be optimized to develop a robust 
system to obtain large number of cells for several migration, invasion and 
differentiation assays in vitro. Ultimately these cells could also be used for 
potential transplantation experiments in vivo.  
 
Adult human stem cells that are intrinsic to various tissues have been described 
and characterized over the years. Stem cells are defined as cells that have 
clonogenic and self-renewing capabilities and that differentiate into multiple cell 
lineages (Weissman, 2000). These cells are capable of maintaining, generating, 
and replacing terminally differentiated cells within their own specific tissue as a 
consequence of physiologic cell turnover or tissue damage due to injury (Slack, 
2000). Because the normal reparative mechanisms seems to be overwhelmed 
when clinically significant airway injury occurs, a logical next step would be to 
aid the regenerative process during recovery. One approach is based on 
identifying and expanding in vitro multipotent adult progenitor cells that are 
capable of regenerating the airway epithelium. The other approach is based on 
harnessing the in vivo availability of endogenous adult stem cells that can be 
manipulated to improve the efficiency of the regeneration process (Körbling and 
Estrov, 2003).  
 
Adult stem cell transplantation is a novel therapeutic path being developed to treat 
various medical conditions. The most common area for adult stem cell 
transplantation has been in the hematopoetic stem cell (HSCs) field. HSCs are 
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well defined and characterized and are used clinically to treat patients with 
hematologic and lymphoid cancers as well as many other hematopetic disorders 
such as anemia and Thalassemia major (Copelan, 2006). Several clinical trials to 
treat patients with myocardial infarctions with the use of mononuclear bone 
marrow cells also seem promising (Strauer et al., 2002). In vitro cultured p63+ 
human keratinocytes using Dr. Howard Green’s culture system used to treat burn 
patients in 1984 (Gallico III et al., 1984) was probably amongst the first adult 
epithelial stem cell therapy developed and approved for human use. This system 
has also been adapted for corneal epithelium and has met with huge success. 
Culture of corneal and limbal stem cells from normal eye yielded p63+ holoclones 
which are engrafted to treat the burnt eye of patients. The clinical results for these 
kinds of corneal transplantations were successful at up to 10 years in more than 
75% of the patients treated (Rama et al., 2010). This culture system with several 
improvements has been used worldwide since the 1980s and during the past 30 
years, no adverse effects have been reported and is approved for clinical use in the 
United States, Japan, Italy, and South Korea (De Luca et al., 2006; Green, 2008) .  
 
No adult stem cells therapeutic system has been developed for the airways to date. 
Owing to the low turn-over rate of stem cells in the lung and the fatally damaged 
lung tissue post several airway diseases; the only way to replace lung tissue to 
restore normal function currently is to perform lung transplantations. As one can 
imagine, lung transplantation is an expensive procedure that achieves only 10 to 
20% survival at 10 years and one that is hampered by a severe shortage of donor 
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organs (Orens and Garrity Jr, 2009). In the recent years, researchers have been 
working on obtaining a cellular, tissue-engineered airway with mechanical 
properties that allow normal functioning, and which is free from the risks of 
rejection. They have adapted tissue engineering techniques along with basic 
biology to reconstruct trachea and bronchi by allotransplantation of recipient’s 
epithelial and mesenchymal cells on tissue engineered scaffolds without the use of 
immunosuppressive therapy (Delaere et al., 2010; Macchiarini et al., 2008) . 
These findings suggest that autologous cells combined with appropriate 
biomaterials might provide successful treatment for patients with serious clinical 
disorders of the airways. While transplantation of the upper airways in humans 
seems favorable, three-dimensional modeling of the lungs has been a challenge 
because the engineered lung should contain lung-specific cells, display the 
branching geometry of the airways and contain a perfusing microvasculature, 
provide barrier function to separate blood from air, and have mechanical 
properties that allow ventilation at physiological pressures. Recently, researchers 
have been working on the construction of a functional, tissue-engineered lung 
with all these properties by employing a scaffold of rat lungs denuded of all 
cellular components. The retained extracellular matrix scaffold provides the 
hierarchical branching structures of airways and vasculature (Petersen et al., 
2010). Seeding cultured, pulmonary epithelium and vascular endothelium cells on 
the acellular lung matrix leads to the formation of native-like lungs capable of gas 
exchange in vivo in the rat model. These novel tissue engineering approaches 
when combined with our knowledge and understanding of stem cells (Kumar et 
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al., 2011) could be developed into a potential treatment strategy for patients with 
severe airway diseases who are awaiting lung transplantations as a mean of 
survival. While still speculative, this mode of treatment could enable 
allotransplantation of human lungs stem cells to improve survival of patients. 
 
Combining stem cell therapy with other treatments may increase therapeutic 
options in the future. Gene therapy has shown encouraging results in promoting 
angiogenesis, but the safety of gene delivery by means of viral vectors has 
become of increasing public concern (Iwaguro et al., 2002). Further, hESC-
derived retinal pigment epithelium (RPE) transplantation in patients with 
Stargardt’s macular dystrophy and dry age-related macular degeneration look 
promising with restoration of vision and no abnormal hyperproliferation, 
tumorigenicity, ectopic tissue formation, or apparent rejection after 4 months 
(Schwartz et al., 2012). The long-term effects of such experiments remain 
unknown and the field of ES cells as therapy in humans has to be pursued with 
extreme caution. 
 
While stem cell therapy is a promising option to treat patients with chronic airway 
diseases, several concerns are yet to be addressed including, cell numbers used for 
transplantation, stem cell survival, delivery route and homing issues, long term 
adverse affects such as uncontrollable growth, tumor initiation, host rejection, etc . 
The second approach of harnessing existing stem cells to improve the 
regenerative capacity of the lungs may be a more feasible and commonly used 
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therapeutic intervention considering the time constraint and urgency for the need 
of improved lung function in severe forms of ARDS as well as unresolved issues 
with adult stem cell transplantations. 
 
Studies in the past have focused on identifying immune modulators that are key to 
limiting the devastating effects of infection. These studies have been very useful 
in developing novel therapeutics to control the extent of lung damage post 
infections. For example, IFITM3 was identified in a functional genomic screen as 
mediating resistance to Influenza A virus, dengue virus and West Nile virus 
infection in vitro (Brass et al., 2009). By potently restricting the replication of 
multiple pathogenic viruses, this key factor of the innate immune response 
protects the hosts from severe forms of infection. Suppression of another 
interesting effecter of early innate immune response, S1P1 on endothelial cells 
results in reduced mortality during infection with a human pathogenic strain of 
influenza virus in mouse models (Teijaro et al., 2011). Researchers have also 
shown that some patients have an increased susceptibility to normal-moderate 
infections because of their genetic predisposition. For example, IFITM3-
compromised individuals are more vulnerable to the initial establishment and 
spread of a H1N1 (2009) virus which results in morbidity (Everitt et al., 2012). 
These results illustrate that modulation of host immune response which play a key 
role in inducing the cytokine storm resulting in a significant pathological 
component of the disease, could be top candidates for pharmacological treatment 
as the first line of defense against fatal infections. 
163 
 
While these studies are extremely beneficial in developing therapeutics they may 
not be very useful for end-stage patients where extensive lung damage has 
impaired lung function of the individuals. We propose that in addition to 
modulating key intrinsic immune effectors, targeting molecules or pathways that 
affect adult stem cells directly, may provide a better and more immediate relief 
strategy (Xian and McKeon, 2012). Systemic and local growth factors almost 
certainly influence stem cells homing and biology. For example, in the airways, 
pulmonary capillary endothelial cells (PCECs) produce angiocrine growth factors 
that induce proliferation of epithelial progenitor cells supporting alveologenesis 
(Ding et al., 2011). In our studies using mouse models we have identified several 
pathways which can be targeted after better understanding to improve the in vivo 
stem cell potential. For example, identifying chemokines that induce the 
migration of the p63+ Krt5+ pods in the damaged alveolar regions, determining 
the mechanism of differentiation of Krt5+ pods into alveolar epithelium and more 
importantly understanding the interaction between the alveolar epithelium and 
micro-vasculature to form potentially functional units of gas exchange could 
provide important modulators for medical intervention.  
 
The combination of basic biology knowledge on airway stem cells and key 
modulators in combination with novel tissue engineering approaches will open up 
a whole new avenue of clinical treatment for patients with fatal infections 
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